JavaScript NENÍ povolen !

Calkins H, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. A report of the Heart Rhythm Society (HRS) task force on catheter and surgical ablation of atrial fibrillation. Heart Rhythm. 2007;4(6):816–861. doi: 10.1016/j.hrthm.2007.04.005. PubMed DOI

Calkins H, et al. 2012 HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for patient selection, procedural techniques, patient management and follow-up, definitions, endpoints, and research trial design. Heart Rhythm. 2012;9(4):632–696.e21. doi: 10.1016/j.hrthm.2011.12.016. PubMed DOI

Jacobs AK, Anderson JL, Halperin JL. The evolution and future of ACC/AHA clinical practice guidelines: a 30-year journey: a report of the American College of Cardiology/American Heart Association task force on practice guidelines. J Am Coll Cardiol. 2014;64(13):1373–1384. doi: 10.1016/j.jacc.2014.06.001. PubMed DOI

Anderson JL. Evolution of the ACC/AHA clinical practice guidelines in perspective: guiding the guidelines. J Am Coll Cardiol. 2015;65(25):2735–2738. doi: 10.1016/j.jacc.2015.04.051. PubMed DOI

January CT, et al. 2014 AHA/ACC/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology/American Heart Association task force on practice guidelines and the Heart Rhythm Society. J Am Coll Cardiol. 2014;64(21):e1–e76. doi: 10.1016/j.jacc.2014.03.022. PubMed DOI

Kirchhof P, et al. 2016 ESC guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur J Cardiothorac Surg. 2016;50(5):e1–e88. doi: 10.1093/ejcts/ezw313. PubMed DOI

Jais P, et al. Catheter ablation versus antiarrhythmic drugs for atrial fibrillation: the A4 study. Circulation. 2008;18(24):2498–2505. doi: 10.1161/CIRCULATIONAHA.108.772582. PubMed DOI

Calkins H, et al. Treatment of atrial fibrillation with antiarrhythmic drugs or radiofrequency ablation: two systematic literature reviews and meta-analyses. Circ Arrhythm Electrophysiol. 2009;2(4):349–361. doi: 10.1161/CIRCEP.108.824789. PubMed DOI

Packer DL, et al. Cryoballoon ablation of pulmonary veins for paroxysmal atrial fibrillation: first results of the north American Arctic front (STOP AF) pivotal trial. J Am Coll Cardiol. 2013;61(16):1713–1723. doi: 10.1016/j.jacc.2012.11.064. PubMed DOI

Kuck KH, et al. Cryoballoon or radiofrequency ablation for paroxysmal atrial fibrillation. N Engl J Med. 2016;374(23):2235–2245. doi: 10.1056/NEJMoa1602014. PubMed DOI

Dukkipati SR, et al. Pulmonary vein isolation using the visually guided laser balloon: a prospective, multicenter, and randomized comparison to standard radiofrequency ablation. J Am Coll Cardiol. 2015;66(12):1350–1360. doi: 10.1016/j.jacc.2015.07.036. PubMed DOI

Reddy VY, et al. Randomized, controlled trial of the safety and effectiveness of a contact force-sensing irrigated catheter for ablation of paroxysmal atrial fibrillation: results of the TactiCath contact force ablation catheter study for atrial fibrillation (TOCCASTAR) study. Circulation. 2015;132(10):907–915. doi: 10.1161/CIRCULATIONAHA.114.014092. PubMed DOI

Natale A, et al. Paroxysmal AF catheter ablation with a contact force sensing catheter: results of the prospective, multicenter SMART-AF trial. J Am Coll Cardiol. 2014;64(7):647–656. doi: 10.1016/j.jacc.2014.04.072. PubMed DOI

Wilber DJ, et al. Comparison of antiarrhythmic drug therapy and radiofrequency catheter ablation in patients with paroxysmal atrial fibrillation: a randomized controlled trial. JAMA. 2010;303(4):333–340. doi: 10.1001/jama.2009.2029. PubMed DOI

Sohara H, et al. HotBalloon ablation of the pulmonary veins for paroxysmal AF: a multicenter randomized trial in Japan. J Am Coll Cardiol. 2016;68(25):2747–2757. doi: 10.1016/j.jacc.2016.10.037. PubMed DOI

Pappone C, et al. A randomized trial of circumferential pulmonary vein ablation versus antiarrhythmic drug therapy in paroxysmal atrial fibrillation: the APAF study. J Am Coll Cardiol. 2006;48(11):2340–2347. doi: 10.1016/j.jacc.2006.08.037. PubMed DOI

Stabile G, et al. Catheter ablation treatment in patients with drug-refractory atrial fibrillation: a prospective, multi-centre, randomized, controlled study (catheter ablation for the cure of atrial fibrillation study) Eur Heart J. 2006;27(2):216–221. doi: 10.1093/eurheartj/ehi583. PubMed DOI

Forleo GB, et al. Catheter ablation of atrial fibrillation in patients with diabetes mellitus type 2: results from a randomized study comparing pulmonary vein isolation versus antiarrhythmic drug therapy. J Cardiovasc Electrophysiol. 2009;20(1):22–28. doi: 10.1111/j.1540-8167.2008.01275.x. PubMed DOI

Verma A, et al. Approaches to catheter ablation for persistent atrial fibrillation. N Engl J Med. 2015;372(19):1812–1822. doi: 10.1056/NEJMoa1408288. PubMed DOI

Scherr D, et al. Five-year outcome of catheter ablation of persistent atrial fibrillation using termination of atrial fibrillation as a procedural endpoint. Circ Arrhythm Electrophysiol. 2015;8(1):18–24. doi: 10.1161/CIRCEP.114.001943. PubMed DOI

Tamborero D, et al. Left atrial posterior wall isolation does not improve the outcome of circumferential pulmonary vein ablation for atrial fibrillation: a prospective randomized study. Circ Arrhythm Electrophysiol. 2009;2(1):35–40. doi: 10.1161/CIRCEP.108.797944. PubMed DOI

Hummel J, et al. Phased RF ablation in persistent atrial fibrillation. Heart Rhythm. 2014;11(2):202–209. doi: 10.1016/j.hrthm.2013.11.009. PubMed DOI

Bassiouny M, et al. Randomized study of persistent atrial fibrillation ablation: ablate in sinus rhythm versus ablate complex-fractionated atrial electrograms in atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9(2):e003596. doi: 10.1161/CIRCEP.115.003596. PubMed DOI

Krittayaphong R, et al. A randomized clinical trial of the efficacy of radiofrequency catheter ablation and amiodarone in the treatment of symptomatic atrial fibrillation. J Med Assoc Thail. 2003;86(Suppl 1):S8–S16. PubMed

Oral H, et al. Circumferential pulmonary-vein ablation for chronic atrial fibrillation. N Engl J Med. 2006;354(9):934–941. doi: 10.1056/NEJMoa050955. PubMed DOI

Mont L, et al. Catheter ablation vs. antiarrhythmic drug treatment of persistent atrial fibrillation: a multicentre, randomized, controlled trial (SARA study) Eur Heart J. 2014;35(8):501–507. doi: 10.1093/eurheartj/eht457. PubMed DOI PMC

Calvo N, et al. Efficacy of circumferential pulmonary vein ablation of atrial fibrillation in endurance athletes. Europace. 2010;12(1):30–36. doi: 10.1093/europace/eup320. PubMed DOI PMC

Furlanello F, et al. Radiofrequency catheter ablation of atrial fibrillation in athletes referred for disabling symptoms preventing usual training schedule and sport competition. J Cardiovasc Electrophysiol. 2008;19(5):457–462. doi: 10.1111/j.1540-8167.2007.01077.x. PubMed DOI

Wazni OM, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. JAMA. 2005;293(21):2634–2640. doi: 10.1001/jama.293.21.2634. PubMed DOI

Cosedis Nielsen J, et al. Radiofrequency ablation as initial therapy in paroxysmal atrial fibrillation. N Engl J Med. 2012;367(17):1587–1595. doi: 10.1056/NEJMoa1113566. PubMed DOI

Morillo CA, et al. Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of paroxysmal atrial fibrillation (RAAFT-2): a randomized trial. JAMA. 2014;311(7):692–700. doi: 10.1001/jama.2014.467. PubMed DOI

Hakalahti A, et al. Radiofrequency ablation vs antiarrhythmic drug therapy as first line treatment of symptomatic atrial fibrillation: systematic review and meta-analysis. Europace. 2015;17(3):370–378. doi: 10.1093/europace/euu376. PubMed DOI

Hocini M, et al. Reverse remodeling of sinus node function after catheter ablation of atrial fibrillation in patients with prolonged sinus pauses. Circulation. 2003;108(10):1172–1175. doi: 10.1161/01.CIR.0000090685.13169.07. PubMed DOI

Chen YW, et al. Pacing or ablation: which is better for paroxysmal atrial fibrillation-related tachycardia-bradycardia syndrome? Pacing Clin Electrophysiol. 2014;37(4):403–411. doi: 10.1111/pace.12340. PubMed DOI

Inada K, et al. The role of successful catheter ablation in patients with paroxysmal atrial fibrillation and prolonged sinus pauses: outcome during a 5-year follow-up. Europace. 2014;16(2):208–213. doi: 10.1093/europace/eut159. PubMed DOI

Chen MS, et al. Pulmonary vein isolation for the treatment of atrial fibrillation in patients with impaired systolic function. J Am Coll Cardiol. 2004;43(6):1004–1009. doi: 10.1016/j.jacc.2003.09.056. PubMed DOI

Gentlesk PJ, et al. Reversal of left ventricular dysfunction following ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18(1):9–14. doi: 10.1111/j.1540-8167.2006.00653.x. PubMed DOI

Khan MN, et al. Pulmonary-vein isolation for atrial fibrillation in patients with HF. N Engl J Med. 2008;359(17):1778–1785. doi: 10.1056/NEJMoa0708234. PubMed DOI

MacDonald MR, et al. Radiofrequency ablation for persistent atrial fibrillation in patients with advanced heart failure and severe left ventricular systolic dysfunction: a randomised controlled trial. Heart. 2011;97(9):740–747. doi: 10.1136/hrt.2010.207340. PubMed DOI

Hunter RJ, et al. A randomized controlled trial of catheter ablation versus medical treatment of atrial fibrillation in heart failure (the CAMTAF trial) Circ Arrhythm Electrophysiol. 2014;7(1):31–38. doi: 10.1161/CIRCEP.113.000806. PubMed DOI

Tondo C, et al. Pulmonary vein vestibule ablation for the control of atrial fibrillation in patients with impaired left ventricular function. Pacing Clin Electrophysiol. 2006;29(9):962–970. doi: 10.1111/j.1540-8159.2006.00471.x. PubMed DOI

Lutomsky BA, et al. Catheter ablation of paroxysmal atrial fibrillation improves cardiac function: a prospective study on the impact of atrial fibrillation ablation on left ventricular function assessed by magnetic resonance imaging. Europace. 2008;10(5):593–599. doi: 10.1093/europace/eun076. PubMed DOI

Choi AD, et al. Ablation vs medical therapy in the setting of symptomatic atrial fibrillation and left ventricular dysfunction. Congest Heart Fail. 2010;16(1):10–14. doi: 10.1111/j.1751-7133.2009.00116.x. PubMed DOI

De Potter T, et al. Left ventricular systolic dysfunction by itself does not influence outcome of atrial fibrillation ablation. Europace. 2010;12(1):24–29. doi: 10.1093/europace/eup309. PubMed DOI PMC

Cha YM, et al. Success of ablation for atrial fibrillation in isolated left ventricular diastolic dysfunction: a comparison to systolic dysfunction and normal ventricular function. Circ Arrhythm Electrophysiol. 2011;4(5):724–732. doi: 10.1161/CIRCEP.110.960690. PubMed DOI

Jones DG, et al. A randomized trial to assess catheter ablation versus rate control in the management of persistent atrial fibrillation in HF. J Am Coll Cardiol. 2013;61(18):1894–1903. doi: 10.1016/j.jacc.2013.01.069. PubMed DOI

Machino-Ohtsuka T, et al. Efficacy, safety, and outcomes of catheter ablation of atrial fibrillation in patients with heart failure with preserved ejection fraction. J Am Coll Cardiol. 2013;62(20):1857–1865. doi: 10.1016/j.jacc.2013.07.020. PubMed DOI

Al Halabi S, et al. Catheter ablation for atrial fibrillation in heart failure patients: a meta-analysis of randomized controlled trials. JACC Clin Electrophysiol. 2015;1(3):200–209. doi: 10.1016/j.jacep.2015.02.018. PubMed DOI PMC

Bunch TJ, et al. Five-year outcomes of catheter ablation in patients with atrial fibrillation and left ventricular systolic dysfunction. J Cardiovasc Electrophysiol. 2015;26(4):363–370. doi: 10.1111/jce.12602. PubMed DOI

Lobo TJ, et al. Atrial fibrillation ablation in systolic dysfunction: clinical and echocardiographic outcomes. Arq Bras Cardiol. 2015;104(1):45–52. PubMed PMC

Ling LH, et al. Sinus rhythm restores ventricular function in patients with cardiomyopathy and no late gadolinium enhancement on cardiac magnetic resonance imaging who undergo catheter ablation for atrial fibrillation. Heart Rhythm. 2013;10(9):1334–1339. doi: 10.1016/j.hrthm.2013.06.019. PubMed DOI

Hsu LF, et al. Catheter ablation for atrial fibrillation in congestive HF. N Engl J Med. 2004;351(23):2373–2383. doi: 10.1056/NEJMoa041018. PubMed DOI

Spragg DD, et al. Complications of catheter ablation for atrial fibrillation: incidence and predictors. J Cardiovasc Electrophysiol. 2008;19(6):627–631. doi: 10.1111/j.1540-8167.2008.01181.x. PubMed DOI

Kusumoto F, et al. Radiofrequency catheter ablation of atrial fibrillation in older patients: outcomes and complications. J Interv Card Electrophysiol. 2009;25(1):31–35. doi: 10.1007/s10840-008-9346-7. PubMed DOI

Bunch TJ, et al. Long-term clinical efficacy and risk of catheter ablation for atrial fibrillation in octogenarians. Pacing Clin Electrophysiol. 2010;33(2):146–152. doi: 10.1111/j.1540-8159.2009.02604.x. PubMed DOI

Santangeli P, et al. Catheter ablation of atrial fibrillation in octogenarians: safety and outcomes. J Cardiovasc Electrophysiol. 2012;23(7):687–693. doi: 10.1111/j.1540-8167.2012.02293.x. PubMed DOI

Nademanee K, et al. Benefits and risks of catheter ablation in elderly patients with atrial fibrillation. Heart Rhythm. 2015;12(1):44–51. doi: 10.1016/j.hrthm.2014.09.049. PubMed DOI

Bunch TJ, et al. The impact of age on 5-year outcomes after atrial fibrillation catheter ablation. J Cardiovasc Electrophysiol. 2016;27(2):141–146. doi: 10.1111/jce.12849. PubMed DOI

Metzner I, et al. Ablation of atrial fibrillation in patients >/=75 years: long-term clinical outcome and safety. Europace. 2016;18(4):543–549. doi: 10.1093/europace/euv229. PubMed DOI

Bunch TJ, et al. Substrate and procedural predictors of outcomes after catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy. J Cardiovasc Electrophysiol. 2008;19(10):1009–1014. doi: 10.1111/j.1540-8167.2008.01192.x. PubMed DOI

Olivotto I, et al. Impact of atrial fibrillation on the clinical course of hypertrophic cardiomyopathy. Circulation. 2001;104(21):2517–2524. doi: 10.1161/hc4601.097997. PubMed DOI

Providencia R, et al. Catheter ablation for atrial fibrillation in hypertrophic cardiomyopathy: a systematic review and meta-analysis. Heart. 2016;102(19):1533–1543. doi: 10.1136/heartjnl-2016-309406. PubMed DOI

Leong-Sit P, et al. Efficacy and risk of atrial fibrillation ablation before 45 years of age. Circ Arrhythm Electrophysiol. 2010;3(5):452–457. doi: 10.1161/CIRCEP.110.938860. PubMed DOI

Chun KR, et al. Catheter ablation of atrial fibrillation in the young: insights from the German ablation registry. Clin Res Cardiol. 2013;102(6):459–468. doi: 10.1007/s00392-013-0553-6. PubMed DOI

Koopman P, et al. Efficacy of radiofrequency catheter ablation in athletes with atrial fibrillation. Europace. 2011;13(10):1386–1393. doi: 10.1093/europace/eur142. PubMed DOI

Forleo GB, et al. Clinical impact of catheter ablation in patients with asymptomatic atrial fibrillation: the IRON-AF (Italian registry on NavX atrial fibrillation ablation procedures) study. Int J Cardiol. 2013;168(4):3968–3970. doi: 10.1016/j.ijcard.2013.06.132. PubMed DOI

Wu L, et al. Comparison of radiofrequency catheter ablation between asymptomatic and symptomatic persistent atrial fibrillation: a propensity score matched analysis. J Cardiovasc Electrophysiol. 2016;27(5):531–535. doi: 10.1111/jce.12930. PubMed DOI

Mohanty S, et al. Catheter ablation of asymptomatic longstanding persistent atrial fibrillation: impact on quality of life, exercise performance, arrhythmia perception, and arrhythmia-free survival. J Cardiovasc Electrophysiol. 2014;25(10):1057–1064. doi: 10.1111/jce.12467. PubMed DOI

U.S. Food and Drug Administration.Summary of Safety and Effectiveness Data: AtriCure Synergy Ablation System, PMA P100046. 2011.

Badhwar V, et al. The society of thoracic surgeons mitral repair/replacement composite score: a report of the society of thoracic surgeons quality measurement task force. Ann Thorac Surg. 2016;101(6):2265–2271. doi: 10.1016/j.athoracsur.2015.11.049. PubMed DOI

Abreu Filho CA, et al. Effectiveness of the maze procedure using cooled-tip radiofrequency ablation in patients with permanent atrial fibrillation and rheumatic mitral valve disease. Circulation. 2005;112(9 Suppl):I20–I25. PubMed

Doukas G, et al. Left atrial radiofrequency ablation during mitral valve surgery for continuous atrial fibrillation: a randomized controlled trial. JAMA. 2005;294(18):2323–2329. doi: 10.1001/jama.294.18.2323. PubMed DOI

Blomstrom-Lundqvist C, et al. A randomized double-blind study of epicardial left atrial cryoablation for permanent atrial fibrillation in patients undergoing mitral valve surgery: the SWEDish multicentre atrial fibrillation study (SWEDMAF) Eur Heart J. 2007;28(23):2902–2908. doi: 10.1093/eurheartj/ehm378. PubMed DOI

Chevalier P, et al. Left atrial radiofrequency ablation during mitral valve surgery: a prospective randomized multicentre study (SAFIR) Arch Cardiovasc Dis. 2009;102(11):769–775. doi: 10.1016/j.acvd.2009.08.010. PubMed DOI

Cheng DC, et al. Surgical ablation for atrial fibrillation in cardiac surgery: a meta-analysis and systematic review. Innovations (Phila) 2010;5(2):84–96. doi: 10.1097/IMI.0b013e3181d9199b. PubMed DOI

Budera P, et al. Comparison of cardiac surgery with left atrial surgical ablation vs. cardiac surgery without atrial ablation in patients with coronary and/or valvular heart disease plus atrial fibrillation: final results of the PRAGUE-12 randomized multicentre study. Eur Heart J. 2012;33(21):2644–2652. doi: 10.1093/eurheartj/ehs290. PubMed DOI PMC

Phan K, et al. Surgical ablation for treatment of atrial fibrillation in cardiac surgery: a cumulative meta-analysis of randomised controlled trials. Heart. 2014;100(9):722–730. doi: 10.1136/heartjnl-2013-305351. PubMed DOI

Gillinov AM, et al. Surgical ablation of atrial fibrillation during mitral-valve surgery. N Engl J Med. 2015;372(15):1399–1409. doi: 10.1056/NEJMoa1500528. PubMed DOI PMC

Rankin JS, et al. The society of thoracic surgeons risk model for operative mortality after multiple valve surgery. Ann Thorac Surg. 2013;95(4):1484–1490. doi: 10.1016/j.athoracsur.2012.11.077. PubMed DOI

Louagie Y, et al. Improved patient survival with concomitant cox maze III procedure compared with heart surgery alone. Ann Thorac Surg. 2009;87(2):440–446. doi: 10.1016/j.athoracsur.2008.10.001. PubMed DOI

Chiappini B, Di Bartolomeo R, Marinelli G. Radiofrequency ablation for atrial fibrillation: different approaches. Asian Cardiovasc Thorac Ann. 2004;12(3):272–277. doi: 10.1177/021849230401200322. PubMed DOI

Barnett SD, Ad N. Surgical ablation as treatment for the elimination of atrial fibrillation: a meta-analysis. J Thorac Cardiovasc Surg. 2006;131(5):1029–1035. doi: 10.1016/j.jtcvs.2005.10.020. PubMed DOI

Edgerton JR, Jackman WM, Mack MJ. A new epicardial lesion set for minimal access left atrial maze: the Dallas lesion set. Ann Thorac Surg. 2009;88(5):1655–1657. doi: 10.1016/j.athoracsur.2009.05.046. PubMed DOI

Edgerton JR, et al. Totally thorascopic surgical ablation of persistent AF and long-standing persistent atrial fibrillation using the “Dallas” lesion set. Heart Rhythm. 2009;6(12 Suppl):S64–S70. doi: 10.1016/j.hrthm.2009.09.011. PubMed DOI

Lockwood D, et al. Linear left atrial lesions in minimally invasive surgical ablation of persistent atrial fibrillation: techniques for assessing conduction block across surgical lesions. Heart Rhythm. 2009;6(12 Suppl):S50–S63. doi: 10.1016/j.hrthm.2009.09.010. PubMed DOI

Malaisrie SC, et al. Atrial fibrillation ablation in patients undergoing aortic valve replacement. J Heart Valve Dis. 2012;21(3):350–357. PubMed

Cherniavsky A, et al. Assessment of results of surgical treatment for persistent atrial fibrillation during coronary artery bypass grafting using implantable loop recorders. Interact Cardiovasc Thorac Surg. 2014;18(6):727–731. doi: 10.1093/icvts/ivu016. PubMed DOI

Yoo JS, et al. Impact of concomitant surgical atrial fibrillation ablation in patients undergoing aortic valve replacement. Circ J. 2014;78(6):1364–1371. doi: 10.1253/circj.CJ-13-1533. PubMed DOI

Driessen AH, et al. Ganglion plexus ablation in advanced atrial fibrillation: the AFACT study. J Am Coll Cardiol. 2016;68(11):1155–1165. doi: 10.1016/j.jacc.2016.06.036. PubMed DOI

Boersma LV, et al. Atrial fibrillation catheter ablation versus surgical ablation treatment (FAST): a 2-center randomized clinical trial. Circulation. 2012;125(1):23–30. doi: 10.1161/CIRCULATIONAHA.111.074047. PubMed DOI

Henn MC, et al. Late outcomes after the Cox maze IV procedure for atrial fibrillation. J Thorac Cardiovasc Surg. 2015;150(5):1168–1176. doi: 10.1016/j.jtcvs.2015.07.102. PubMed DOI PMC

Krul SP, et al. Navigating the mini-maze: systematic review of the first results and progress of minimally-invasive surgery in the treatment of atrial fibrillation. Int J Cardiol. 2013;166(1):132–140. doi: 10.1016/j.ijcard.2011.10.011. PubMed DOI

Cox JL, et al. The surgical treatment of atrial fibrillation. III. Development of a definitive surgical procedure. J Thorac Cardiovasc Surg. 1991;101(4):569–583. PubMed

Rodriguez E, et al. Minimally invasive bi-atrial CryoMaze operation for atrial fibrillation. Oper Tech Thorac Cardiovasc Surg. 2009;14(3):208–223. doi: 10.1053/j.optechstcvs.2009.06.009. DOI

Wolf RK, et al. Video-assisted bilateral pulmonary vein isolation and left atrial appendage exclusion for atrial fibrillation. J Thorac Cardiovasc Surg. 2005;130(3):797–802. doi: 10.1016/j.jtcvs.2005.03.041. PubMed DOI

Edgerton JR, et al. Minimally invasive pulmonary vein isolation and partial autonomic denervation for surgical treatment of atrial fibrillation. Ann Thorac Surg. 2008;86(1):35–38. doi: 10.1016/j.athoracsur.2008.03.071. PubMed DOI

Edgerton JR, et al. Minimally invasive surgical ablation of atrial fibrillation: six-month results. J Thorac Cardiovasc Surg. 2009;138(1):109–113. doi: 10.1016/j.jtcvs.2008.09.080. PubMed DOI

Beyer E, Lee R, Lam BK. Point: minimally invasive bipolar radiofrequency ablation of lone atrial fibrillation: early multicenter results. J Thorac Cardiovasc Surg. 2009;137(3):521–526. doi: 10.1016/j.jtcvs.2008.11.031. PubMed DOI

Kearney K, et al. A systematic review of surgical ablation versus catheter ablation for atrial fibrillation. Ann Cardiothorac Surg. 2014;3(1):15–29. PubMed PMC

Ad N, et al. Surgical ablation of atrial fibrillation trends and outcomes in North America. J Thorac Cardiovasc Surg. 2012;144(5):1051–1060. doi: 10.1016/j.jtcvs.2012.07.065. PubMed DOI

Driessen AH, et al. Electrophysiologically guided thoracoscopic surgery for advanced atrial fibrillation: 5-year follow-up. J Am Coll Cardiol. 2017;69(13):1753–1754. doi: 10.1016/j.jacc.2017.01.035. PubMed DOI

Khargi K, et al. Surgical treatment of atrial fibrillation; a systematic review. Eur J Cardiothorac Surg. 2005;27(2):258–265. doi: 10.1016/j.ejcts.2004.11.003. PubMed DOI

Wazni OM, et al. Atrial arrhythmias after surgical maze: findings during catheter ablation. J Am Coll Cardiol. 2006;48(7):1405–1409. doi: 10.1016/j.jacc.2006.05.061. PubMed DOI

Magnano AR, et al. Mechanisms of atrial tachyarrhythmias following surgical atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2006;17(4):366–373. doi: 10.1111/j.1540-8167.2006.00419.x. PubMed DOI

McElderry HT, et al. Proarrhythmic aspects of atrial fibrillation surgery: mechanisms of postoperative macroreentrant tachycardias. Circulation. 2008;117(2):155–162. doi: 10.1161/CIRCULATIONAHA.107.688358. PubMed DOI

McCarthy PM, et al. Where does atrial fibrillation surgery fail? Implications for increasing effectiveness of ablation. J Thorac Cardiovasc Surg. 2010;139(4):860–867. doi: 10.1016/j.jtcvs.2009.12.038. PubMed DOI

Zeng Y, et al. Recurrent atrial arrhythmia after minimally invasive pulmonary vein isolation for atrial fibrillation. Ann Thorac Surg. 2010;90(2):510–515. doi: 10.1016/j.athoracsur.2010.04.063. PubMed DOI

Lee R, et al. Surgical treatment for isolated atrial fibrillation: minimally invasive vs. classic cut and sew maze. Innovations (Phila) 2011;6(6):373–377. doi: 10.1097/IMI.0b013e318248f3f4. PubMed DOI

Kuck KH, et al. Impact of complete versus incomplete circumferential lines around the pulmonary veins during catheter ablation of paroxysmal atrial fibrillation: results from the gap-atrial fibrillation-German atrial fibrillation competence network 1 trial. Circ Arrhythm Electrophysiol. 2016;9(1):e003337. doi: 10.1161/CIRCEP.115.003337. PubMed DOI

Verma A, et al. Response of atrial fibrillation to pulmonary vein antrum isolation is directly related to resumption and delay of pulmonary vein conduction. Circulation. 2005;112(5):627–635. doi: 10.1161/CIRCULATIONAHA.104.533190. PubMed DOI

Macle L, et al. Adenosine-guided pulmonary vein isolation for the treatment of paroxysmal atrial fibrillation: an international, multicentre, randomised superiority trial. Lancet. 2015;386(9994):672–679. doi: 10.1016/S0140-6736(15)60026-5. PubMed DOI

Cheema A, et al. Incidence and time course of early recovery of pulmonary vein conduction after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18(4):387–391. doi: 10.1111/j.1540-8167.2007.00760.x. PubMed DOI

Rajappan K, et al. Acute and chronic pulmonary vein reconnection after atrial fibrillation ablation: a prospective characterization of anatomical sites. Pacing Clin Electrophysiol. 2008;31(12):1598–1605. doi: 10.1111/j.1540-8159.2008.01232.x. PubMed DOI

Bansch D, et al. Circumferential pulmonary vein isolation: wait or stop early after initial successful pulmonary vein isolation? Europace. 2013;15(2):183–188. doi: 10.1093/europace/eus205. PubMed DOI

Nakamura K, et al. Optimal observation time after completion of circumferential pulmonary vein isolation for atrial fibrillation to prevent chronic pulmonary vein reconnections. Int J Cardiol. 2013;168(6):5300–5310. doi: 10.1016/j.ijcard.2013.08.011. PubMed DOI

Wang XH, et al. Early identification and treatment of PV re-connections: role of observation time and impact on clinical results of atrial fibrillation ablation. Europace. 2007;9(7):481–486. doi: 10.1093/europace/eum101. PubMed DOI

Sauer WH, et al. Atrioventricular nodal reentrant tachycardia in patients referred for atrial fibrillation ablation: response to ablation that incorporates slow-pathway modification. Circulation. 2006;114(3):191–195. doi: 10.1161/CIRCULATIONAHA.106.621896. PubMed DOI

Ninomiya Y, et al. Usefulness of the adenosine triphosphate with a sufficient observation period for detecting reconduction after pulmonary vein isolation. Pacing Clin Electrophysiol. 2009;32(10):1307–1312. doi: 10.1111/j.1540-8159.2009.02478.x. PubMed DOI

Yamane T, et al. Repeated provocation of time- and ATP-induced early pulmonary vein reconnections after pulmonary vein isolation: eliminating paroxysmal atrial fibrillation in a single procedure. Circ Arrhythm Electrophysiol. 2011;4(5):601–608. doi: 10.1161/CIRCEP.110.960138. PubMed DOI

Kobori A, et al. Adenosine triphosphate-guided pulmonary vein isolation for atrial fibrillation: the UNmasking dormant electrical Reconduction by adenosine TriPhosphate (UNDER-ATP) trial. Eur Heart J. 2015;36(46):3276–3287. PubMed

Pratola C, et al. Radiofrequency ablation of atrial fibrillation: is the persistence of all intraprocedural targets necessary for long-term maintenance of sinus rhythm? Circulation. 2008;117(2):136–143. doi: 10.1161/CIRCULATIONAHA.106.678789. PubMed DOI

Jiang RH, et al. Incidence of pulmonary vein conduction recovery in patients without clinical recurrence after ablation of paroxysmal atrial fibrillation: mechanistic implications. Heart Rhythm. 2014;11(6):969–976. doi: 10.1016/j.hrthm.2014.03.015. PubMed DOI

Arentz T, et al. “Dormant” pulmonary vein conduction revealed by adenosine after ostial radiofrequency catheter ablation. J Cardiovasc Electrophysiol. 2004;15(9):1041–1047. doi: 10.1046/j.1540-8167.2004.04031.x. PubMed DOI

Tritto M, et al. Adenosine restores atrio-venous conduction after apparently successful ostial isolation of the pulmonary veins. Eur Heart J. 2004;25(23):2155–2163. doi: 10.1016/j.ehj.2004.08.023. PubMed DOI

Datino T, et al. Mechanisms by which adenosine restores conduction in dormant canine pulmonary veins. Circulation. 2010;121(8):963–972. doi: 10.1161/CIRCULATIONAHA.109.893107. PubMed DOI

Dallaglio PD, et al. The role of adenosine in pulmonary vein isolation: a critical review. Cardiol Res Pract. 2016;2016:8632509. doi: 10.1155/2016/8632509. PubMed DOI PMC

Kapa S, et al. Dose-dependent pulmonary vein reconnection in response to adenosine: relevance of atrioventricular block during infusion. J Interv Card Electrophysiol. 2016;47(1):117–123. doi: 10.1007/s10840-016-0149-y. PubMed DOI

Andrade JG, et al. Pulmonary vein isolation using “contact force” ablation: the effect on dormant conduction and long-term freedom from recurrent atrial fibrillation–a prospective study. Heart Rhythm. 2014;11(11):1919–1924. doi: 10.1016/j.hrthm.2014.07.033. PubMed DOI

Eitel C, et al. Circumferential pulmonary vein isolation and linear left atrial ablation as a single-catheter technique to achieve bidirectional conduction block: the pace-and-ablate approach. Heart Rhythm. 2010;7(2):157–164. doi: 10.1016/j.hrthm.2009.10.003. PubMed DOI

Steven D, et al. Loss of pace capture on the ablation line: a new marker for complete radiofrequency lesions to achieve pulmonary vein isolation. Heart Rhythm. 2010;7(3):323–330. doi: 10.1016/j.hrthm.2009.11.011. PubMed DOI

Andrade JG, et al. Pulmonary vein isolation using a pace-capture-guided versus an adenosine-guided approach: effect on dormant conduction and long-term freedom from recurrent atrial fibrillation–a prospective study. Circ Arrhythm Electrophysiol. 2013;6(6):1103–1108. doi: 10.1161/CIRCEP.113.000454. PubMed DOI

Steven D, et al. Benefit of pulmonary vein isolation guided by loss of pace capture on the ablation line: results from a prospective 2-center randomized trial. J Am Coll Cardiol. 2013;62(1):44–50. doi: 10.1016/j.jacc.2013.03.059. PubMed DOI

Schaeffer B, et al. Loss of pace capture on the ablation line during pulmonary vein isolation versus “dormant conduction”: is adenosine expendable? J Cardiovasc Electrophysiol. 2015;26(10):1075–1080. doi: 10.1111/jce.12759. PubMed DOI

Gerstenfeld EP, et al. Utility of exit block for identifying electrical isolation of the pulmonary veins. J Cardiovasc Electrophysiol. 2002;13(10):971–979. doi: 10.1046/j.1540-8167.2002.00971.x. PubMed DOI

Vijayaraman P, et al. Assessment of exit block following pulmonary vein isolation: far-field capture masquerading as entrance without exit block. Heart Rhythm. 2012;9(10):1653–1659. doi: 10.1016/j.hrthm.2012.06.004. PubMed DOI

Ip JE, et al. Method for differentiating left superior pulmonary vein exit conduction from pseudo-exit conduction. Pacing Clin Electrophysiol. 2013;36(3):299–308. doi: 10.1111/pace.12062. PubMed DOI

Spector P. Principles of cardiac electric propagation and their implications for re-entrant arrhythmias. Circ Arrhythm Electrophysiol. 2013;6(3):655–661. doi: 10.1161/CIRCEP.113.000311. PubMed DOI

Chen S, et al. Blocking the pulmonary vein to left atrium conduction in addition to the entrance block enhances clinical efficacy in atrial fibrillation ablation. Pacing Clin Electrophysiol. 2012;35(5):524–531. doi: 10.1111/j.1540-8159.2012.03343.x. PubMed DOI

Kim JY, et al. Achievement of successful pulmonary vein isolation: methods of adenosine testing and incremental benefit of exit block. J Interv Card Electrophysiol. 2016;46(3):315–324. doi: 10.1007/s10840-016-0122-9. PubMed DOI

Perez FJ, et al. Long-term outcomes after catheter ablation of cavo-tricuspid isthmus dependent atrial flutter: a meta-analysis. Circ Arrhythm Electrophysiol. 2009;2(4):393–401. doi: 10.1161/CIRCEP.109.871665. PubMed DOI

Patel NJ, et al. Contemporary utilization and safety outcomes of catheter ablation of atrial flutter in the United States: analysis of 89,638 procedures. Heart Rhythm. 2016;13(6):1317–1325. doi: 10.1016/j.hrthm.2016.02.005. PubMed DOI

Wazni O, et al. Randomized study comparing combined pulmonary vein-left atrial junction disconnection and cavotricuspid isthmus ablation versus pulmonary vein-left atrial junction disconnection alone in patients presenting with typical atrial flutter and atrial fibrillation. Circulation. 2003;108(20):2479–2483. doi: 10.1161/01.CIR.0000101684.88679.AB. PubMed DOI

Natale A, et al. Prospective randomized comparison of antiarrhythmic therapy versus first-line radiofrequency ablation in patients with atrial flutter. J Am Coll Cardiol. 2000;35(7):1898–1904. doi: 10.1016/S0735-1097(00)00635-5. PubMed DOI

Pappone C, et al. Prevention of iatrogenic atrial tachycardia after ablation of atrial fibrillation: a prospective randomized study comparing circumferential pulmonary vein ablation with a modified approach. Circulation. 2004;110(19):3036–3042. doi: 10.1161/01.CIR.0000147186.83715.95. PubMed DOI

Sawhney N, et al. Circumferential pulmonary vein ablation with additional linear ablation results in an increased incidence of left atrial flutter compared with segmental pulmonary vein isolation as an initial approach to ablation of paroxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(3):243–248. doi: 10.1161/CIRCEP.109.924878. PubMed DOI

Chae S, et al. Atrial tachycardia after circumferential pulmonary vein ablation of atrial fibrillation: mechanistic insights, results of catheter ablation, and risk factors for recurrence. J Am Coll Cardiol. 2007;50(18):1781–1787. doi: 10.1016/j.jacc.2007.07.044. PubMed DOI

Ouyang F, et al. Characterization of reentrant circuits in left atrial macroreentrant tachycardia: critical isthmus block can prevent atrial tachycardia recurrence. Circulation. 2002;105(16):1934–1942. doi: 10.1161/01.CIR.0000015077.12680.2E. PubMed DOI

Matsuo S, et al. Peri-mitral atrial flutter in patients with atrial fibrillation ablation. Heart Rhythm. 2010;7(1):2–8. doi: 10.1016/j.hrthm.2009.09.067. PubMed DOI

Tzeis S, et al. The modified anterior line: an alternative linear lesion in perimitral flutter. J Cardiovasc Electrophysiol. 2010;21(6):665–670. doi: 10.1111/j.1540-8167.2009.01681.x. PubMed DOI

Chen SA, Tai CT. Catheter ablation of atrial fibrillation originating from the non-pulmonary vein foci. J Cardiovasc Electrophysiol. 2005;16(2):229–232. doi: 10.1046/j.1540-8167.2005.40665.x. PubMed DOI

Haissaguerre M, et al. Spontaneous initiation of atrial fibrillation by ectopic beats originating in the pulmonary veins. N Engl J Med. 1998;339(10):659–666. doi: 10.1056/NEJM199809033391003. PubMed DOI

Lee SH, et al. Predictors of non-pulmonary vein ectopic beats initiating paroxysmal atrial fibrillation: implication for catheter ablation. J Am Coll Cardiol. 2005;46(6):1054–1059. doi: 10.1016/j.jacc.2005.06.016. PubMed DOI

Hsieh MH, et al. Alterations of heart rate variability after radiofrequency catheter ablation of focal atrial fibrillation originating from pulmonary veins. Circulation. 1999;100(22):2237–2243. doi: 10.1161/01.CIR.100.22.2237. PubMed DOI

Shah D, et al. Nonpulmonary vein foci: do they exist? Pacing Clin Electrophysiol. 2003;26(7 Pt 2):1631–1635. doi: 10.1046/j.1460-9592.2003.t01-1-00243.x. PubMed DOI

Lin D, et al. Provocability of atrial fibrillation triggers during pulmonary vein isolation in patients with infrequent AF [abstract] Heart Rhythm. 2004;1(Suppl):S231.

Di Biase L, et al. Left atrial appendage: an underrecognized trigger site of atrial fibrillation. Circulation. 2010;122(2):109–118. doi: 10.1161/CIRCULATIONAHA.109.928903. PubMed DOI

Santangeli P, et al. Prevalence and distribution of focal triggers in persistent and long-standing persistent atrial fibrillation. Heart Rhythm. 2016;13(2):374–382. doi: 10.1016/j.hrthm.2015.10.023. PubMed DOI

Lin WS, et al. Catheter ablation of paroxysmal atrial fibrillation initiated by non-pulmonary vein ectopy. Circulation. 2003;107(25):3176–3183. doi: 10.1161/01.CIR.0000074206.52056.2D. PubMed DOI

Lee RJ, et al. Percutaneous alternative to the maze procedure for the treatment of persistent or long-standing persistent atrial fibrillation (aMAZE trial): rationale and design. Am Heart J. 2015;170(6):1184–1194. doi: 10.1016/j.ahj.2015.09.019. PubMed DOI

Zhao Y, et al. Importance of non-pulmonary vein triggers ablation to achieve long-term freedom from paroxysmal atrial fibrillation in patients with low ejection fraction. Heart Rhythm. 2016;13(1):141–149. doi: 10.1016/j.hrthm.2015.08.029. PubMed DOI

Dixit S, et al. Randomized ablation strategies for the treatment of persistent atrial fibrillation: RASTA study. Circ Arrhythm Electrophysiol. 2012;5(2):287–294. doi: 10.1161/CIRCEP.111.966226. PubMed DOI

Neuzil P, et al. Electrical reconnection after pulmonary vein isolation is contingent on contact force during initial treatment: results from the EFFICAS I study. Circ Arrhythm Electrophysiol. 2013;6(2):327–333. doi: 10.1161/CIRCEP.113.000374. PubMed DOI

Yokoyama K, et al. Novel contact force sensor incorporated in irrigated radiofrequency ablation catheter predicts lesion size and incidence of steam pop and thrombus. Circ Arrhythm Electrophysiol. 2008;1(5):354–362. doi: 10.1161/CIRCEP.108.803650. PubMed DOI

Ikeda A, et al. Relationship between catheter contact force and radiofrequency lesion size and incidence of steam pop in the beating canine heart: electrogram amplitude, impedance, and electrode temperature are poor predictors of electrode-tissue contact force and lesion size. Circ Arrhythm Electrophysiol. 2014;7(6):1174–1180. doi: 10.1161/CIRCEP.113.001094. PubMed DOI

Nakagawa H, et al. Locations of high contact force during left atrial mapping in atrial fibrillation patients: electrogram amplitude and impedance are poor predictors of electrode-tissue contact force for ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2013;6(4):746–753. doi: 10.1161/CIRCEP.113.978320. PubMed DOI

Nakagawa H, et al. Prospective study to test the ability to create RF lesions at predicted depth and diameter using a new formula incorporating contact force, radiofrequency power and application time (force-power-time index) in the beating heart [abstract] Heart Rhythm. 2014;11(Suppl):S548.

Kumar S, et al. Predictive value of impedance changes for real-time contact force measurements during catheter ablation of atrial arrhythmias in humans. Heart Rhythm. 2013;10(7):962–969. doi: 10.1016/j.hrthm.2013.03.022. PubMed DOI

Kumar S, et al. Prospective characterization of catheter-tissue contact force at different anatomic sites during antral pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2012;5(6):1124–1129. doi: 10.1161/CIRCEP.112.972208. PubMed DOI

Reddy VY, et al. The relationship between contact force and clinical outcome during radiofrequency catheter ablation of atrial fibrillation in the TOCCATA study. Heart Rhythm. 2012;9(11):1789–1795. doi: 10.1016/j.hrthm.2012.07.016. PubMed DOI

Haldar S, et al. Contact force sensing technology identifies sites of inadequate contact and reduces acute pulmonary vein reconnection: a prospective case control study. Int J Cardiol. 2013;168(2):1160–1166. doi: 10.1016/j.ijcard.2012.11.072. PubMed DOI

Perna F, et al. Assessment of catheter tip contact force resulting in cardiac perforation in swine atria using force sensing technology. Circ Arrhythm Electrophysiol. 2011;4(2):218–224. doi: 10.1161/CIRCEP.110.959429. PubMed DOI

Kimura M, et al. Comparison of lesion formation between contact force-guided and non-guided circumferential pulmonary vein isolation: a prospective, randomized study. Heart Rhythm. 2014;11(6):984–991. doi: 10.1016/j.hrthm.2014.03.019. PubMed DOI

Sohns C, et al. Quantitative magnetic resonance imaging analysis of the relationship between contact force and left atrial scar formation after catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(2):138–145. doi: 10.1111/jce.12298. PubMed DOI

Martinek M, et al. Clinical impact of an open-irrigated radiofrequency catheter with direct force measurement on atrial fibrillation ablation. Pacing Clin Electrophysiol. 2012;35(11):1312–1318. doi: 10.1111/j.1540-8159.2012.03503.x. PubMed DOI

Marijon E, et al. Real-time contact force sensing for pulmonary vein isolation in the setting of paroxysmal atrial fibrillation: procedural and 1-year results. J Cardiovasc Electrophysiol. 2014;25(2):130–137. doi: 10.1111/jce.12303. PubMed DOI

Sigmund E, et al. Optimizing radiofrequency ablation of paroxysmal and persistent atrial fibrillation by direct catheter force measurement-a case-matched comparison in 198 patients. Pacing Clin Electrophysiol. 2015;38(2):201–208. doi: 10.1111/pace.12549. PubMed DOI

Ullah W, et al. Randomized trial comparing pulmonary vein isolation using the SmartTouch catheter with or without real-time contact force data. Heart Rhythm. 2016;13(9):1761–1767. doi: 10.1016/j.hrthm.2016.05.011. PubMed DOI

Wakili R, et al. Impact of real-time contact force and impedance measurement in pulmonary vein isolation procedures for treatment of atrial fibrillation. Clin Res Cardiol. 2014;103(2):97–106. doi: 10.1007/s00392-013-0625-7. PubMed DOI

Kumagai K, et al. A new approach for complete isolation of the posterior left atrium including pulmonary veins for atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18(10):1047–1052. doi: 10.1111/j.1540-8167.2007.00911.x. PubMed DOI

Yamaguchi Y, et al. Long-term effects of box isolation on sympathovagal balance in atrial fibrillation. Circ J. 2010;74(6):1096–1103. doi: 10.1253/circj.CJ-09-0899. PubMed DOI

Kumagai K. Catheter ablation of atrial fibrillation. State of the Art Circ J. 2011;75(10):2305–2311. PubMed

Kim JS, et al. Does isolation of the left atrial posterior wall improve clinical outcomes after radiofrequency catheter ablation for persistent atrial fibrillation? A prospective randomized clinical trial. Int J Cardiol. 2015;181:277–283. doi: 10.1016/j.ijcard.2014.12.035. PubMed DOI

He X, et al. Left atrial posterior wall isolation reduces the recurrence of atrial fibrillation: a meta-analysis. J Interv Card Electrophysiol. 2016;46(3):267–274. doi: 10.1007/s10840-016-0124-7. PubMed DOI

Di Biase L, et al. Left atrial appendage isolation in patients with long-standing persistent AF undergoing catheter ablation: BELIEF trial. J Am Coll Cardiol. 2016;68(18):1929–1940. doi: 10.1016/j.jacc.2016.07.770. PubMed DOI

Di Biase L, et al. Ablation versus amiodarone for treatment of persistent atrial fibrillation in patients with congestive heart failure and an implanted device: results from the AATAC multicenter randomized trial. Circulation. 2016;133(17):1637–1644. doi: 10.1161/CIRCULATIONAHA.115.019406. PubMed DOI

Morillo CA, et al. Chronic rapid atrial pacing. Structural, functional, and electrophysiological characteristics of a new model of sustained atrial fibrillation. Circulation. 1995;91(5):1588–1595. doi: 10.1161/01.CIR.91.5.1588. PubMed DOI

Harada A, et al. Atrial activation during chronic atrial fibrillation in patients with isolated mitral valve disease. Ann Thorac Surg. 1996;61(1):104–111. doi: 10.1016/0003-4975(95)00824-1. PubMed DOI

Gray RA, Pertsov AM, Jalife J. Spatial and temporal organization during cardiac fibrillation. Nature. 1998;392(6671):75–78. doi: 10.1038/32164. PubMed DOI

Berenfeld O, et al. Spatially distributed dominant excitation frequencies reveal hidden organization in atrial fibrillation in the Langendorff-perfused sheep heart. J Cardiovasc Electrophysiol. 2000;11(8):869–879. doi: 10.1111/j.1540-8167.2000.tb00066.x. PubMed DOI

Mansour M, et al. Left-to-right gradient of atrial frequencies during acute atrial fibrillation in the isolated sheep heart. Circulation. 2001;103(21):2631–2636. doi: 10.1161/01.CIR.103.21.2631. PubMed DOI

Lazar S, et al. Presence of left-to-right atrial frequency gradient in paroxysmal but not persistent atrial fibrillation in humans. Circulation. 2004;110(20):3181–3186. doi: 10.1161/01.CIR.0000147279.91094.5E. PubMed DOI

Atienza F, et al. Real-time dominant frequency mapping and ablation of dominant frequency sites in atrial fibrillation with left-to-right frequency gradients predicts long-term maintenance of sinus rhythm. Heart Rhythm. 2009;6(1):33–40. doi: 10.1016/j.hrthm.2008.10.024. PubMed DOI PMC

Atienza F, et al. Comparison of radiofrequency catheter ablation of drivers and circumferential pulmonary vein isolation in atrial fibrillation: a noninferiority randomized multicenter RADAR-AF trial. J Am Coll Cardiol. 2014;64(23):2455–2467. doi: 10.1016/j.jacc.2014.09.053. PubMed DOI

Vogler J, et al. Pulmonary vein isolation versus defragmentation: the CHASE-AF clinical trial. J Am Coll Cardiol. 2015;66(24):2743–2752. doi: 10.1016/j.jacc.2015.09.088. PubMed DOI

Haissaguerre M, et al. Catheter ablation of long-lasting persistent atrial fibrillation: clinical outcome and mechanisms of subsequent arrhythmias. J Cardiovasc Electrophysiol. 2005;16(11):1138–1147. doi: 10.1111/j.1540-8167.2005.00308.x. PubMed DOI

Nademanee K, et al. A new approach for catheter ablation of atrial fibrillation: mapping of the electrophysiologic substrate. J Am Coll Cardiol. 2004;43(11):2044–2053. doi: 10.1016/j.jacc.2003.12.054. PubMed DOI

O'Neill MD, et al. Long-term follow-up of persistent atrial fibrillation ablation using termination as a procedural endpoint. Eur Heart J. 2009;30(9):1105–1112. doi: 10.1093/eurheartj/ehp063. PubMed DOI

Lo LW, et al. Predicting factors for atrial fibrillation acute termination during catheter ablation procedures: implications for catheter ablation strategy and long-term outcome. Heart Rhythm. 2009;6(3):311–318. doi: 10.1016/j.hrthm.2008.11.013. PubMed DOI

Zhang Z, et al. Linear ablation following pulmonary vein isolation in patients with atrial fibrillation: a meta-analysis. Pacing Clin Electrophysiol. 2016;39(6):623–630. doi: 10.1111/pace.12841. PubMed DOI

Kim TH, et al. Linear ablation in addition to circumferential pulmonary vein isolation (Dallas lesion set) does not improve clinical outcome in patients with paroxysmal atrial fibrillation: a prospective randomized study. Europace. 2015;17(3):388–395. doi: 10.1093/europace/euu245. PubMed DOI

Wynn GJ, et al. Biatrial linear ablation in sustained nonpermanent AF: results of the substrate modification with ablation and antiarrhythmic drugs in nonpermanent atrial fibrillation (SMAN-PAF) trial. Heart Rhythm. 2016;13(2):399–406. doi: 10.1016/j.hrthm.2015.10.006. PubMed DOI

Kottkamp H, et al. Box isolation of fibrotic areas (BIFA): a patient-tailored substrate modification approach for ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27(1):22–30. doi: 10.1111/jce.12870. PubMed DOI

Kottkamp H, Bender R, Berg J. Catheter ablation of atrial fibrillation: how to modify the substrate? J Am Coll Cardiol. 2015;65(2):196–206. doi: 10.1016/j.jacc.2014.10.034. PubMed DOI

Rolf S, et al. Tailored atrial substrate modification based on low-voltage areas in catheter ablation of atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7(5):825–833. doi: 10.1161/CIRCEP.113.001251. PubMed DOI

Bai R, et al. Proven isolation of the pulmonary vein antrum with or without left atrial posterior wall isolation in patients with persistent atrial fibrillation. Heart Rhythm. 2016;13(1):132–140. doi: 10.1016/j.hrthm.2015.08.019. PubMed DOI

Cutler MJ, et al. Impact of voltage mapping to guide whether to perform ablation of the posterior wall in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27(1):13–21. doi: 10.1111/jce.12830. PubMed DOI

Yang G, et al. Catheter ablation of nonparoxysmal atrial fibrillation using electrophysiologically guided substrate modification during sinus rhythm after pulmonary vein isolation. Circ Arrhythm Electrophysiol. 2016;9(2):e003382. doi: 10.1161/CIRCEP.115.003382. PubMed DOI

Verma A, et al. Pre-existent left atrial scarring in patients undergoing pulmonary vein antrum isolation: an independent predictor of procedural failure. J Am Coll Cardiol. 2005;45(2):285–292. doi: 10.1016/j.jacc.2004.10.035. PubMed DOI

Kapa S, et al. Contact electroanatomic mapping derived voltage criteria for characterizing left atrial scar in patients undergoing ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(10):1044–1052. doi: 10.1111/jce.12452. PubMed DOI

Oakes RS, et al. Detection and quantification of left atrial structural remodeling with delayed-enhancement magnetic resonance imaging in patients with atrial fibrillation. Circulation. 2009;119(13):1758–1767. doi: 10.1161/CIRCULATIONAHA.108.811877. PubMed DOI PMC

McGann C, et al. Atrial fibrillation ablation outcome is predicted by left atrial remodeling on MRI. Circ Arrhythm Electrophysiol. 2014;7(1):23–30. doi: 10.1161/CIRCEP.113.000689. PubMed DOI PMC

Dagres N, et al. Current ablation techniques for persistent atrial fibrillation: results of the European heart rhythm association survey. Europace. 2015;17(10):1596–1600. doi: 10.1093/europace/euv323. PubMed DOI

Nademanee K, et al. Clinical outcomes of catheter substrate ablation for high-risk patients with atrial fibrillation. J Am Coll Cardiol. 2008;51(8):843–849. doi: 10.1016/j.jacc.2007.10.044. PubMed DOI

Haissaguerre M, et al. Localized sources maintaining atrial fibrillation organized by prior ablation. Circulation. 2006;113(5):616–625. doi: 10.1161/CIRCULATIONAHA.105.546648. PubMed DOI

Haissaguerre M, et al. Catheter ablation of long-lasting persistent atrial fibrillation: critical structures for termination. J Cardiovasc Electrophysiol. 2005;16(11):1125–1137. doi: 10.1111/j.1540-8167.2005.00307.x. PubMed DOI

Takahashi Y, et al. Characterization of electrograms associated with termination of chronic atrial fibrillation by catheter ablation. J Am Coll Cardiol. 2008;51(10):1003–1010. doi: 10.1016/j.jacc.2007.10.056. PubMed DOI

Singh SM, et al. Intraprocedural use of ibutilide to organize and guide ablation of complex fractionated atrial electrograms: preliminary assessment of a modified step-wise approach to ablation of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(6):608–616. doi: 10.1111/j.1540-8167.2009.01671.x. PubMed DOI

Narayan SM, et al. Classifying fractionated electrograms in human atrial fibrillation using monophasic action potentials and activation mapping: evidence for localized drivers, rate acceleration, and nonlocal signal etiologies. Heart Rhythm. 2011;8(2):244–253. doi: 10.1016/j.hrthm.2010.10.020. PubMed DOI PMC

Verma A, et al. Selective CFAE targeting for atrial fibrillation study (SELECT AF): clinical rationale, design, and implementation. J Cardiovasc Electrophysiol. 2011;22(5):541–547. doi: 10.1111/j.1540-8167.2010.01959.x. PubMed DOI

Quintanilla JG, et al. Mechanistic approaches to detect, target, and ablate the drivers of atrial fibrillation. Circ Arrhythm Electrophysiol. 2016;9(1):e002481. doi: 10.1161/CIRCEP.115.002481. PubMed DOI PMC

Hansen BJ, et al. Atrial fibrillation driven by micro-anatomic intramural re-entry revealed by simultaneous sub-epicardial and sub-endocardial optical mapping in explanted human hearts. Eur Heart J. 2015;36(35):2390–2401. doi: 10.1093/eurheartj/ehv233. PubMed DOI PMC

Cuculich PS, et al. Noninvasive characterization of epicardial activation in humans with diverse atrial fibrillation patterns. Circulation. 2010;122(S):1364–1372. doi: 10.1161/CIRCULATIONAHA.110.945709. PubMed DOI PMC

Haissaguerre M, et al. Driver domains in persistent atrial fibrillation. Circulation. 2014;130(7):530–538. doi: 10.1161/CIRCULATIONAHA.113.005421. PubMed DOI

Narayan SM, et al. Ablation of rotor and focal sources reduces late recurrence of atrial fibrillation compared with trigger ablation alone: extended follow-up of the CONFIRM trial (conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation) J Am Coll Cardiol. 2014;63(17):1761–1768. doi: 10.1016/j.jacc.2014.02.543. PubMed DOI PMC

Lin YJ, et al. Prevalence, characteristics, mapping, and catheter ablation of potential rotors in nonparoxysmal atrial fibrillation. Circ Arrhythm Electrophysiol. 2013;6(5):851–858. doi: 10.1161/CIRCEP.113.000318. PubMed DOI

Lin Y-J, et al. Benefits of atrial substrate modification guided by electrogram similarity and phase mapping techniques to eliminate rotors and focal sources versus conventional defragmentation in persistent atrial fibrillation. JACC: Clinical Electrophysiology. 2016;2(6):667–678. PubMed

Miller JM, et al. Initial independent outcomes from focal impulse and rotor modulation ablation for atrial fibrillation: multicenter FIRM registry. J Cardiovasc Electrophysiol. 2014;25(9):921–929. doi: 10.1111/jce.12474. PubMed DOI PMC

Lin YJ, et al. Electrophysiological characteristics and catheter ablation in patients with paroxysmal right atrial fibrillation. Circulation. 2005;112(12):1692–1700. doi: 10.1161/CIRCULATIONAHA.104.512731. PubMed DOI

Narayan SM, et al. Treatment of atrial fibrillation by the ablation of localized sources: CONFIRM (conventional ablation for atrial fibrillation with or without focal impulse and rotor modulation) trial. J Am Coll Cardiol. 2012;60(7):628–636. doi: 10.1016/j.jacc.2012.05.022. PubMed DOI PMC

Rappel WJ, Narayan SM. Theoretical considerations for mapping activation in human cardiac fibrillation. Chaos. 2013;23(2):023113. doi: 10.1063/1.4807098. PubMed DOI PMC

Gianni C, et al. Acute and early outcomes of focal impulse and rotor modulation (FIRM)-guided rotors-only ablation in patients with nonparoxysmal atrial fibrillation. Heart Rhythm. 2016;13(4):830–835. doi: 10.1016/j.hrthm.2015.12.028. PubMed DOI

Narayan SM, Zaman JA. Mechanistically based mapping of human cardiac fibrillation. J Physiol. 2016;594(9):2399–2415. doi: 10.1113/JP270513. PubMed DOI PMC

Sommer P, et al. Successful repeat catheter ablation of recurrent long-standing persistent atrial fibrillation with rotor elimination as the procedural endpoint: a case series. J Cardiovasc Electrophysiol. 2016;27(3):274–280. doi: 10.1111/jce.12874. PubMed DOI

Buch E, et al. Long-term clinical outcomes of focal impulse and rotor modulation for treatment of atrial fibrillation: a multicenter experience. Heart Rhythm. 2016;13(3):636–641. doi: 10.1016/j.hrthm.2015.10.031. PubMed DOI PMC

Benharash P, et al. Quantitative analysis of localized sources identified by focal impulse and rotor modulation mapping in atrial fibrillation. Circ Arrhythm Electrophysiol. 2015;8(3):554–561. doi: 10.1161/CIRCEP.115.002721. PubMed DOI PMC

Ramanathan C, et al. Noninvasive electrocardiographic imaging for cardiac electrophysiology and arrhythmia. Nat Med. 2004;10(4):422–428. doi: 10.1038/nm1011. PubMed DOI PMC

Lim HS, et al. Noninvasive mapping to guide atrial fibrillation ablation. Card Electrophysiol Clin. 2015;7(1):89–98. doi: 10.1016/j.ccep.2014.11.004. PubMed DOI

Yamashita S, et al. Body surface mapping to guide atrial fibrillation ablation. Arrhythmia Electrophysiol Rev. 2015;4(3):172–176. doi: 10.15420/aer.2015.4.3.172. PubMed DOI PMC

Guillem MS, et al. Noninvasive mapping of human atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20(5):507–513. doi: 10.1111/j.1540-8167.2008.01356.x. PubMed DOI

Guillem MS, et al. Noninvasive localization of maximal frequency sites of atrial fibrillation by body surface potential mapping. Circ Arrhythm Electrophysiol. 2013;6(2):294–301. doi: 10.1161/CIRCEP.112.000167. PubMed DOI PMC

Rodrigo M, et al. Body surface localization of left and right atrial high-frequency rotors in atrial fibrillation patients: a clinical-computational study. Heart Rhythm. 2014;11(9):1584–1591. doi: 10.1016/j.hrthm.2014.05.013. PubMed DOI PMC

Armour JA, et al. Gross and microscopic anatomy of the human intrinsic cardiac nervous system. Anat Rec. 1997;247(2):289–298. doi: 10.1002/(SICI)1097-0185(199702)247:2<289::AID-AR15>3.0.CO;2-L. PubMed DOI

Po SS, Nakagawa H, Jackman WM. Localization of left atrial ganglionated plexi in patients with atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20(10):1186–1189. doi: 10.1111/j.1540-8167.2009.01515.x. PubMed DOI

Patterson E, et al. Triggered firing in pulmonary veins initiated by in vitro autonomic nerve stimulation. Heart Rhythm. 2005;2(6):624–631. doi: 10.1016/j.hrthm.2005.02.012. PubMed DOI

Choi EK, et al. Intrinsic cardiac nerve activity and paroxysmal atrial tachyarrhythmia in ambulatory dogs. Circulation. 2010;121(24):2615–2623. doi: 10.1161/CIRCULATIONAHA.109.919829. PubMed DOI PMC

Katritsis DG, et al. Autonomic denervation added to pulmonary vein isolation for paroxysmal atrial fibrillation: a randomized clinical trial. J Am Coll Cardiol. 2013;62(24):2318–2325. doi: 10.1016/j.jacc.2013.06.053. PubMed DOI

Nakagawa H, et al. Pathophysiologic basis of autonomic ganglionated plexus ablation in patients with atrial fibrillation. Heart Rhythm. 2009;6(12 Suppl):S26–S34. doi: 10.1016/j.hrthm.2009.07.029. PubMed DOI

Bettoni M, Zimmermann M. Autonomic tone variations before the onset of paroxysmal atrial fibrillation. Circulation. 2002;105(23):2753–2759. doi: 10.1161/01.CIR.0000018443.44005.D8. PubMed DOI

Pauza DH, et al. Morphology, distribution, and variability of the epicardiac neural ganglionated subplexuses in the human heart. Anat Rec. 2000;259(4):353–382. doi: 10.1002/1097-0185(20000801)259:4<353::AID-AR10>3.0.CO;2-R. PubMed DOI

Scherlag BJ, et al. Electrical stimulation to identify neural elements on the heart: their role in atrial fibrillation. J Interv Card Electrophysiol. 2005;13(Suppl 1):37–42. doi: 10.1007/s10840-005-2492-2. PubMed DOI

Patterson E, et al. Sodium-calcium exchange initiated by the Ca2+ transient: an arrhythmia trigger within pulmonary veins. J Am Coll Cardiol. 2006;47(6):1196–1206. doi: 10.1016/j.jacc.2005.12.023. PubMed DOI

Lemola K, et al. Pulmonary vein region ablation in experimental vagal atrial fibrillation: role of pulmonary veins versus autonomic ganglia. Circulation. 2008;117(4):470–477. doi: 10.1161/CIRCULATIONAHA.107.737023. PubMed DOI

Nishida K, et al. The role of pulmonary veins vs. autonomic ganglia in different experimental substrates of canine atrial fibrillation. Cardiovasc Res. 2011;89(4):825–833. doi: 10.1093/cvr/cvq332. PubMed DOI

Nishida K, et al. Atrial fibrillation ablation: translating basic mechanistic insights to the patient. J Am Coll Cardiol. 2014;64:823–831. doi: 10.1016/j.jacc.2014.06.1172. PubMed DOI

Stavrakis S, et al. The role of the autonomic ganglia in atrial fibrillation. JACC Clin Electrophysiol. 2015;1(1-2):1–13. doi: 10.1016/j.jacep.2015.01.005. PubMed DOI PMC

Pokushalov E, et al. Left atrial ablation at the anatomic areas of ganglionated plexi for paroxysmal atrial fibrillation. Pacing Clin Electrophysiol. 2010;33(10):1231–1238. doi: 10.1111/j.1540-8159.2010.02800.x. PubMed DOI

Pokushalov E, et al. Ganglionated plexi ablation for long-standing persistent atrial fibrillation. Europace. 2010;12(3):342–346. doi: 10.1093/europace/euq014. PubMed DOI

Pokushalov E, et al. Catheter versus surgical ablation of atrial fibrillation after a failed initial pulmonary vein isolation procedure: a randomized controlled trial. J Cardiovasc Electrophysiol. 2013;24(12):1338–1343. doi: 10.1111/jce.12245. PubMed DOI

Pokushalov E, et al. Ganglionated plexus ablation vs linear ablation in patients undergoing pulmonary vein isolation for persistent/long-standing persistent atrial fibrillation: a randomized comparison. Heart Rhythm. 2013;10(9):1280–1286. doi: 10.1016/j.hrthm.2013.04.016. PubMed DOI

Lloyd-Jones DM, et al. Lifetime risk for development of atrial fibrillation: the Framingham heart study. Circulation. 2004;110(9):1042–1046. doi: 10.1161/01.CIR.0000140263.20897.42. PubMed DOI

Mahajan R, et al. Electrophysiological, electroanatomical, and structural remodeling of the atria as consequences of sustained obesity. J Am Coll Cardiol. 2015;66(1):1–11. doi: 10.1016/j.jacc.2015.04.058. PubMed DOI

Wokhlu A, et al. Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. J Cardiovasc Electrophysiol. 2010;21(10):1071–1078. doi: 10.1111/j.1540-8167.2010.01786.x. PubMed DOI

Dublin S, et al. Risk of new-onset atrial fibrillation in relation to body mass index. Arch Intern Med. 2006;166(21):2322–2328. doi: 10.1001/archinte.166.21.2322. PubMed DOI

Gami AS, et al. Obstructive sleep apnea, obesity, and the risk of incident atrial fibrillation. J Am Coll Cardiol. 2007;49(5):565–571. doi: 10.1016/j.jacc.2006.08.060. PubMed DOI

Tedrow UB, et al. The long- and short-term impact of elevated body mass index on the risk of new atrial fibrillation the WHS (Women's health study) J Am Coll Cardiol. 2010;55(21):2319–2327. doi: 10.1016/j.jacc.2010.02.029. PubMed DOI PMC

Huxley RR, et al. Absolute and attributable risks of atrial fibrillation in relation to optimal and borderline risk factors: the atherosclerosis risk in communities (ARIC) study. Circulation. 2011;123(14):1501–1508. doi: 10.1161/CIRCULATIONAHA.110.009035. PubMed DOI PMC

Munger TM, et al. Electrophysiological and hemodynamic characteristics associated with obesity in patients with atrial fibrillation. J Am Coll Cardiol. 2012;60(9):851–860. doi: 10.1016/j.jacc.2012.03.042. PubMed DOI

Abed HS, et al. Obesity results in progressive atrial structural and electrical remodeling: implications for atrial fibrillation. Heart Rhythm. 2013;10(1):90–100. doi: 10.1016/j.hrthm.2012.08.043. PubMed DOI

Richter B, et al. Is inducibility of atrial fibrillation after radio frequency ablation really a relevant prognostic factor? Eur Heart J. 2006;27(21):2553–2559. doi: 10.1093/eurheartj/ehl307. PubMed DOI

Jongnarangsin K, et al. Body mass index, obstructive sleep apnea, and outcomes of catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19(7):668–672. doi: 10.1111/j.1540-8167.2008.01118.x. PubMed DOI

Shah AN, et al. Long-term outcome following successful pulmonary vein isolation: pattern and prediction of very late recurrence. J Cardiovasc Electrophysiol. 2008;19(7):661–667. doi: 10.1111/j.1540-8167.2008.01101.x. PubMed DOI

Chang SL, et al. Comparison of outcome in catheter ablation of atrial fibrillation in patients with versus without the metabolic syndrome. Am J Cardiol. 2009;103(1):67–72. doi: 10.1016/j.amjcard.2008.08.042. PubMed DOI

Letsas KP, et al. Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace. 2009;11(2):158–163. doi: 10.1093/europace/eun309. PubMed DOI

Tang RB, et al. Metabolic syndrome and risk of recurrence of atrial fibrillation after catheter ablation. Circ J. 2009;73(3):438–443. doi: 10.1253/circj.CJ-08-0832. PubMed DOI

Jin Hwang H, et al. Atrial electroanatomical remodeling as a determinant of different outcomes between two current ablation strategies: circumferential pulmonary vein isolation vs pulmonary vein isolation. Clin Cardiol. 2010;33(3):E69–E74. doi: 10.1002/clc.20567. PubMed DOI PMC

Patel D, et al. Outcomes and complications of catheter ablation for atrial fibrillation in females. Heart Rhythm. 2010;7(2):167–172. doi: 10.1016/j.hrthm.2009.10.025. PubMed DOI

Patel D, et al. Safety and efficacy of pulmonary vein antral isolation in patients with obstructive sleep apnea: the impact of continuous positive airway pressure. Circ Arrhythm Electrophysiol. 2010;3(5):445–451. doi: 10.1161/CIRCEP.109.858381. PubMed DOI

Patel D, et al. The impact of statins and renin-angiotensin-aldosterone system blockers on pulmonary vein antrum isolation outcomes in post-menopausal females. Europace. 2010;12(3):322–330. doi: 10.1093/europace/eup387. PubMed DOI

Chao TF, et al. Associations between renal function, atrial substrate properties and outcome of catheter ablation in patients with paroxysmal atrial fibrillation. Circ J. 2011;75(10):2326–2332. doi: 10.1253/circj.CJ-11-0178. PubMed DOI

Winkle RA, et al. Relation of early termination of persistent atrial fibrillation by cardioversion or drugs to ablation outcomes. Am J Cardiol. 2011;108(3):374–379. doi: 10.1016/j.amjcard.2011.03.055. PubMed DOI

Wong CX, et al. Pericardial fat is associated with atrial fibrillation severity and ablation outcome. J Am Coll Cardiol. 2011;57(17):1745–1751. doi: 10.1016/j.jacc.2010.11.045. PubMed DOI

Kang JH, et al. Prediction of long-term outcomes of catheter ablation of persistent atrial fibrillation by parameters of preablation DC cardioversion. J Cardiovasc Electrophysiol. 2012;23(11):1165–1170. doi: 10.1111/j.1540-8167.2012.02339.x. PubMed DOI

Mohanty S, et al. Impact of metabolic syndrome on procedural outcomes in patients with atrial fibrillation undergoing catheter ablation. J Am Coll Cardiol. 2012;59(14):1295–1301. doi: 10.1016/j.jacc.2011.11.051. PubMed DOI

Ejima K, et al. Impact of diastolic dysfunction on the outcome of catheter ablation in patients with atrial fibrillation. Int J Cardiol. 2013;164(1):88–93. doi: 10.1016/j.ijcard.2011.06.093. PubMed DOI

Letsas KP, et al. The impact of body mass index on the efficacy and safety of catheter ablation of atrial fibrillation. Int J Cardiol. 2013;164(1):94–98. doi: 10.1016/j.ijcard.2011.06.092. PubMed DOI

Wong CX, et al. Obesity and the risk of incident, post-operative, and post-ablation atrial fibrillation: a meta-analysis of 626,603 individuals in 51 studies. JACC: Clinical Electrophysiology. 2015;1(3):139–152. PubMed

Alonso A, et al. Effect of an intensive lifestyle intervention on atrial fibrillation risk in individuals with type 2 diabetes: the Look AHEAD randomized trial. Am Heart J. 2015;170(4):770–777.e5. doi: 10.1016/j.ahj.2015.07.026. PubMed DOI PMC

Pathak RK, et al. Aggressive risk factor reduction study for atrial fibrillation and implications for the outcome of ablation: the ARREST-AF cohort study. J Am Coll Cardiol. 2014;64(21):2222–2231. doi: 10.1016/j.jacc.2014.09.028. PubMed DOI

Bitter T, et al. Sleep-disordered breathing and cardiac arrhythmias. Can J Cardiol. 2015;31(7):928–934. doi: 10.1016/j.cjca.2015.04.022. PubMed DOI

Fletcher EC. Effect of episodic hypoxia on sympathetic activity and blood pressure. Respir Physiol. 2000;119(2-3):189–197. doi: 10.1016/S0034-5687(99)00114-0. PubMed DOI

Kraiczi H, et al. Increased vasoconstrictor sensitivity in obstructive sleep apnea. J Appl Physiol. 1985;89(2):493–498. PubMed

Ghias M, et al. The role of ganglionated plexi in apnea-related atrial fibrillation. J Am Coll Cardiol. 2009;54(22):2075–2083. doi: 10.1016/j.jacc.2009.09.014. PubMed DOI

Linz D, et al. Negative tracheal pressure during obstructive respiratory events promotes atrial fibrillation by vagal activation. Heart Rhythm. 2011;8(9):1436–1443. doi: 10.1016/j.hrthm.2011.03.053. PubMed DOI

Linz D, et al. Renal sympathetic denervation suppresses postapneic blood pressure rises and atrial fibrillation in a model for sleep apnea. Hypertension. 2012;60(1):172–178. doi: 10.1161/HYPERTENSIONAHA.112.191965. PubMed DOI

Linz D, et al. Effect of renal denervation on neurohumoral activation triggering atrial fibrillation in obstructive sleep apnea. Hypertension. 2013;62(4):767–774. doi: 10.1161/HYPERTENSIONAHA.113.01728. PubMed DOI

Iwasaki YK, et al. Determinants of atrial fibrillation in an animal model of obesity and acute obstructive sleep apnea. Heart Rhythm. 2012;9(9):1409–1416.e1. doi: 10.1016/j.hrthm.2012.03.024. PubMed DOI

Iwasaki YK, et al. Atrial fibrillation promotion with long-term repetitive obstructive sleep apnea in a rat model. J Am Coll Cardiol. 2014;64(19):2013–2023. doi: 10.1016/j.jacc.2014.05.077. PubMed DOI

Dimitri H, et al. Atrial remodeling in obstructive sleep apnea: implications for atrial fibrillation. Heart Rhythm. 2012;9(3):321–327. doi: 10.1016/j.hrthm.2011.10.017. PubMed DOI

Stevenson IH, et al. Atrial electrophysiology is altered by acute hypercapnia but not hypoxemia: implications for promotion of atrial fibrillation in pulmonary disease and sleep apnea. Heart Rhythm. 2010;7(9):1263–1270. doi: 10.1016/j.hrthm.2010.03.020. PubMed DOI

Holmqvist F, et al. Impact of obstructive sleep apnea and continuous positive airway pressure therapy on outcomes in patients with atrial fibrillation-results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) Am Heart J. 2015;169(5):647–654.e2. doi: 10.1016/j.ahj.2014.12.024. PubMed DOI

Kwon Y, et al. Association of sleep characteristics with atrial fibrillation: the multi-ethnic study of atherosclerosis. Thorax. 2015;70(9):873–879. doi: 10.1136/thoraxjnl-2014-206655. PubMed DOI PMC

Kanagala R, et al. Obstructive sleep apnea and the recurrence of atrial fibrillation. Circulation. 2003;107(20):2589–2594. PubMed

Fein AS, et al. Treatment of obstructive sleep apnea reduces the risk of atrial fibrillation recurrence after catheter ablation. J Am Coll Cardiol. 2013;62(4):300–305. doi: 10.1016/j.jacc.2013.03.052. PubMed DOI

Matiello M, et al. Low efficacy of atrial fibrillation ablation in severe obstructive sleep apnoea patients. Europace. 2010;12(8):1084–1089. doi: 10.1093/europace/euq128. PubMed DOI

Naruse Y, et al. Concomitant obstructive sleep apnea increases the recurrence of atrial fibrillation following radiofrequency catheter ablation of atrial fibrillation: clinical impact of continuous positive airway pressure therapy. Heart Rhythm. 2013;10(3):331–337. doi: 10.1016/j.hrthm.2012.11.015. PubMed DOI

Neilan TG, et al. Effect of sleep apnea and continuous positive airway pressure on cardiac structure and recurrence of atrial fibrillation. J Am Heart Assoc. 2013;2(6):e000421. doi: 10.1161/JAHA.113.000421. PubMed DOI PMC

Li L, et al. Efficacy of catheter ablation of atrial fibrillation in patients with obstructive sleep apnoea with and without continuous positive airway pressure treatment: a meta-analysis of observational studies. Europace. 2014;16(9):1309–1314. doi: 10.1093/europace/euu066. PubMed DOI

Raitt MH, et al. Reversal of electrical remodeling after cardioversion of persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15(5):507–512. doi: 10.1046/j.1540-8167.2004.03217.x. PubMed DOI

Chalfoun N, et al. Reverse electrical remodeling of the atria post cardioversion in patients who remain in sinus rhythm assessed by signal averaging of the P-wave. Pacing Clin Electrophysiol. 2007;30(4):502–509. doi: 10.1111/j.1540-8159.2007.00700.x. PubMed DOI

Igarashi M, et al. Effect of restoration of sinus rhythm by extensive antiarrhythmic drugs in predicting results of catheter ablation of persistent atrial fibrillation. Am J Cardiol. 2010;106(1):62–68. doi: 10.1016/j.amjcard.2010.02.016. PubMed DOI

Rivard L, et al. Improved outcome following restoration of sinus rhythm prior to catheter ablation of persistent atrial fibrillation: a comparative multicenter study. Heart Rhythm. 2012;9(7):1025–1030. doi: 10.1016/j.hrthm.2012.02.016. PubMed DOI

Mohanty S, et al. Effect of periprocedural amiodarone on procedure outcome in patients with long-standing persistent atrial fibrillation undergoing extended pulmonary vein antrum isolation: results from a randomized study (SPECULATE) Heart Rhythm. 2015;12(3):477–483. doi: 10.1016/j.hrthm.2014.11.016. PubMed DOI

Robbins IM, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation. Circulation. 1998;98(17):1769–1775. doi: 10.1161/01.CIR.98.17.1769. PubMed DOI

Ernst S, et al. Total pulmonary vein occlusion as a consequence of catheter ablation for atrial fibrillation mimicking primary lung disease. J Cardiovasc Electrophysiol. 2003;14(4):366–370. doi: 10.1046/j.1540-8167.2003.02334.x. PubMed DOI

Mansour M, et al. Assessment of pulmonary vein anatomic variability by magnetic resonance imaging: implications for catheter ablation techniques for atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15(4):387–393. doi: 10.1046/j.1540-8167.2004.03515.x. PubMed DOI

Holmes DR, Jr, Monahan KH, Packer D. Pulmonary vein stenosis complicating ablation for atrial fibrillation: clinical spectrum and interventional considerations. JACC Cardiovasc Interv. 2009;2(4):267–276. doi: 10.1016/j.jcin.2008.12.014. PubMed DOI

Fender EA, Packer DL, Holmes Jr. DR. Pulmonary vein stenosis after atrial fibrillation ablation. EuroIntervention. 2016;12(Suppl X):X31–X34. doi: 10.4244/EIJV12SXA7. PubMed DOI

Di Biase L, et al. Pulmonary vein total occlusion following catheter ablation for atrial fibrillation: clinical implications after long-term follow-up. J Am Coll Cardiol. 2006;48(12):2493–2499. doi: 10.1016/j.jacc.2006.08.038. PubMed DOI

Prieto LR, et al. Comparison of stent versus balloon angioplasty for pulmonary vein stenosis complicating pulmonary vein isolation. J Cardiovasc Electrophysiol. 2008;19(7):673–678. doi: 10.1111/j.1540-8167.2008.01110.x. PubMed DOI

Packer DL, et al. Clinical presentation, investigation, and management of pulmonary vein stenosis complicating ablation for atrial fibrillation. Circulation. 2005;111(5):546–554. doi: 10.1161/01.CIR.0000154541.58478.36. PubMed DOI

Taylor GW, et al. Pathological effects of extensive radiofrequency energy applications in the pulmonary veins in dogs. Circulation. 2000;101(14):1736–1742. doi: 10.1161/01.CIR.101.14.1736. PubMed DOI

Arentz T, et al. Incidence of pulmonary vein stenosis 2 years after radiofrequency catheter ablation of refractory atrial fibrillation. Eur Heart J. 2003;24(10):963–969. doi: 10.1016/S0195-668X(03)00002-2. PubMed DOI

Tse HF, et al. Pulmonary vein isolation using transvenous catheter cryoablation for treatment of atrial fibrillation without risk of pulmonary vein stenosis. J Am Coll Cardiol. 2003;42(4):752–758. doi: 10.1016/S0735-1097(03)00788-5. PubMed DOI

Kasper L, et al. Hemoptysis and lung disease as a manifestation of pulmonary vein stenosis after cryoballoon catheter ablation for atrial fibrillation. Pol Arch Med Wewn. 2016;126(1-2):94–96. PubMed

Dong J, et al. Incidence and predictors of pulmonary vein stenosis following catheter ablation of atrial fibrillation using the anatomic pulmonary vein ablation approach: results from paired magnetic resonance imaging. J Cardiovasc Electrophysiol. 2005;16(8):845–852. doi: 10.1111/j.1540-8167.2005.40680.x. PubMed DOI

Hoyt RH, et al. Transvenous catheter cryoablation for treatment of atrial fibrillation: results of a feasibility study. Pacing Clin Electrophysiol. 2005;28(Suppl 1):S78–S82. doi: 10.1111/j.1540-8159.2005.00060.x. PubMed DOI

Saad EB, et al. Pulmonary vein stenosis after catheter ablation of atrial fibrillation: emergence of a new clinical syndrome. Ann Intern Med. 2003;138(8):634–638. doi: 10.7326/0003-4819-138-8-200304150-00010. PubMed DOI

Hilbert S, et al. Pulmonary vein collateral formation as a long-term result of post-interventional pulmonary vein stenosis. Eur Heart J. 2016;37(31):2474. doi: 10.1093/eurheartj/ehv753. PubMed DOI

Hilbert S, Sommer P, Bollmann A. Pulmonary vein dilatation in a case of total pulmonary vein occlusion: contemporary approach using a combination of 3D-mapping system and image integration. Catheter Cardiovasc Interv. 2016;88(7):E227–E232. doi: 10.1002/ccd.26251. PubMed DOI

Fender EA, et al. Severe pulmonary vein stenosis resulting from ablation for atrial fibrillation: presentation, management, and clinical outcomes. Circulation. 2016;134(23):1812–1821. doi: 10.1161/CIRCULATIONAHA.116.021949. PubMed DOI

De Potter TJ, et al. Drug-eluting stents for the treatment of pulmonary vein stenosis after atrial fibrillation ablation. Europace. 2011;13(1):57–61. doi: 10.1093/europace/euq419. PubMed DOI

Kanter KR, Kirshbom PM, Kogon BE. Surgical repair of pulmonary venous stenosis: a word of caution. Ann Thorac Surg. 2014;98(5):1687–1691. doi: 10.1016/j.athoracsur.2014.05.082. PubMed DOI

Patel NS, et al. Successful surgical repair of iatrogenic pulmonary vein stenosis. J Cardiovasc Electrophysiol. 2012;23(6):656–658. doi: 10.1111/j.1540-8167.2011.02272.x. PubMed DOI

Bharat A, et al. Lung transplant is a viable treatment option for patients with congenital and acquired pulmonary vein stenosis. J Heart Lung Transplant. 2013;32(6):621–625. doi: 10.1016/j.healun.2013.03.002. PubMed DOI

Ponamgi SP, et al. Catheter-based intervention for pulmonary vein stenosis due to fibrosing mediastinitis: the Mayo Clinic experience. Int J Cardiol Heart Vasc. 2015;8:103–107. PubMed PMC

Mohanty S, et al. Impact of alcohol intake on thromboembolic events following catheter ablation for atrial fibrillation. J Am Coll Cardiol. 2014;63(12_S).

Di Biase L, et al. Esophageal capsule endoscopy after radiofrequency catheter ablation for atrial fibrillation: documented higher risk of luminal esophageal damage with general anesthesia as compared with conscious sedation. Circ Arrhythm Electrophysiol. 2009;2(2):108–112. doi: 10.1161/CIRCEP.108.815266. PubMed DOI

Cappato R, et al. Worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circulation. 2005;111(9):1100–1105. doi: 10.1161/01.CIR.0000157153.30978.67. PubMed DOI

Pappone C, et al. Atrio-esophageal fistula as a complication of percutaneous transcatheter ablation of atrial fibrillation. Circulation. 2004;109(22):2724–2726. doi: 10.1161/01.CIR.0000131866.44650.46. PubMed DOI

Martinek M, et al. Identification of a high-risk population for esophageal injury during radiofrequency catheter ablation of atrial fibrillation: procedural and anatomical considerations. Heart Rhythm. 2010;7(9):1224–1230. doi: 10.1016/j.hrthm.2010.02.027. PubMed DOI

Singh SM, et al. Clinical outcomes after repair of left atrial esophageal fistulas occurring after atrial fibrillation ablation procedures. Heart Rhythm. 2013;10(11):1591–1597. doi: 10.1016/j.hrthm.2013.08.012. PubMed DOI

Bunch TJ, et al. Temporary esophageal stenting allows healing of esophageal perforations following atrial fibrillation ablation procedures. J Cardiovasc Electrophysiol. 2006;17(4):435–439. doi: 10.1111/j.1540-8167.2006.00464.x. PubMed DOI

Cappato R, et al. Prevalence and causes of fatal outcome in catheter ablation of atrial fibrillation. J Am Coll Cardiol. 2009;53(19):1798–1803. doi: 10.1016/j.jacc.2009.02.022. PubMed DOI

Tan C, Coffey A. Atrioesophageal fistula after surgical unipolar radiofrequency atrial ablation for atrial fibrillation. Ann Thorac Surg. 2013;95(3):e61–e62. doi: 10.1016/j.athoracsur.2012.08.066. PubMed DOI

Mohanty S. Outcomes of atrio-esophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting. J Cardiovasc Electrophysiol. 2014;25(9):E6. doi: 10.1111/jce.12494. PubMed DOI

Mohanty S, et al. Outcomes of atrioesophageal fistula following catheter ablation of atrial fibrillation treated with surgical repair versus esophageal stenting. J Cardiovasc Electrophysiol. 2014;25(6):579–584. doi: 10.1111/jce.12386. PubMed DOI

Cappato R, et al. Updated worldwide survey on the methods, efficacy, and safety of catheter ablation for human atrial fibrillation. Circ Arrhythm Electrophysiol. 2010;3(1):32–38. doi: 10.1161/CIRCEP.109.859116. PubMed DOI

Gillinov AM, Pettersson G, Rice TW. Esophageal injury during radiofrequency ablation for atrial fibrillation. J Thorac Cardiovasc Surg. 2001;122(6):1239–1240. doi: 10.1067/mtc.2001.118041. PubMed DOI

Mohr FW, et al. Curative treatment of atrial fibrillation with intraoperative radiofrequency ablation: short-term and midterm results. J Thorac Cardiovasc Surg. 2002;123(5):919–927. doi: 10.1067/mtc.2002.120730. PubMed DOI

Doll N, et al. Esophageal perforation during left atrial radiofrequency ablation: is the risk too high? J Thorac Cardiovasc Surg. 2003;125(4):836–842. doi: 10.1067/mtc.2003.165. PubMed DOI

Sonmez B, et al. A fatal complication due to radiofrequency ablation for atrial fibrillation: atrio-esophageal fistula. Ann Thorac Surg. 2003;76(1):281–283. doi: 10.1016/S0003-4975(03)00006-7. PubMed DOI

Scanavacca MI, et al. Left atrial-esophageal fistula following radiofrequency catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2004;15(8):960–962. doi: 10.1046/j.1540-8167.2004.04083.x. PubMed DOI

Borchert B, et al. Lethal atrioesophageal fistula after pulmonary vein isolation using high-intensity focused ultrasound (HIFU) Heart Rhythm. 2008;5(1):145–148. doi: 10.1016/j.hrthm.2007.08.023. PubMed DOI

Ghia KK, et al. A nationwide survey on the prevalence of atrioesophageal fistula after left atrial radiofrequency catheter ablation. J Interv Card Electrophysiol. 2009;24(1):33–36. doi: 10.1007/s10840-008-9307-1. PubMed DOI

Gilcrease GW, Stein JB. A delayed case of fatal atrioesophageal fistula following radiofrequency ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(6):708–711. doi: 10.1111/j.1540-8167.2009.01688.x. PubMed DOI

Stockigt F, et al. Atrioesophageal fistula after cryoballoon pulmonary vein isolation. J Cardiovasc Electrophysiol. 2012;23(11):1254–1257. doi: 10.1111/j.1540-8167.2012.02324.x. PubMed DOI

Yousuf O, Calkins H. Sounding the warning on the potential for oesophageal injury resulting from use of the nMARQ for ablation of atrial fibrillation. Europace. 2015;17(3):343–344. doi: 10.1093/europace/euu380. PubMed DOI

Jackson PG, et al. The vagus plays a role in the anti-reflux barrier by controlling both the lower esophageal sphincter pressure and crural diaphragm activity. J Am Coll Surg. 2005;201(3 Suppl):S11. doi: 10.1016/j.jamcollsurg.2005.06.007. DOI

Nolker G, et al. Esophageal acid levels after pulmonary vein isolation for atrial fibrillation. Pacing Clin Electrophysiol. 2009;32(Suppl 1):S228–S230. doi: 10.1111/j.1540-8159.2008.02292.x. PubMed DOI

Medeiros De Vasconcelos JT, et al. Atrial-oesophageal fistula following percutaneous radiofrequency catheter ablation of atrial fibrillation: the risk still persists. Europace. 2017;19(2):250–258. PubMed

Rillig A, et al. Modified energy settings are mandatory to minimize oesophageal injury using the novel multipolar irrigated radiofrequency ablation catheter for pulmonary vein isolation. Europace. 2015;17(3):396–402. doi: 10.1093/europace/euu269. PubMed DOI

Chavez P, et al. Atrioesophageal fistula following ablation procedures for atrial fibrillation: systematic review of case reports. Open Heart. 2015;2(1):e000257. doi: 10.1136/openhrt-2015-000257. PubMed DOI PMC

Mateos JC, et al. Simplified method for esophagus protection during radiofrequency catheter ablation of atrial fibrillation–prospective study of 704 cases. Rev Bras Cir Cardiovasc. 2015;30(2):139–147. PubMed PMC

Shim HB, et al. Successful management of atrio-esophageal fistula after cardiac radiofrequency catheter ablation. Korean J Thorac Cardiovasc Surg. 2013;46(2):142–145. doi: 10.5090/kjtcs.2013.46.2.142. PubMed DOI PMC

Black-Maier E, et al. Risk of atrioesophageal fistula formation with contact-force sensing catheters. Heart Rhythm. 2017;S1547–5271(17):30452–30456. PubMed

Santangeli P, et al. Ablation of atrial fibrillation under therapeutic warfarin reduces periprocedural complications: evidence from a meta-analysis. Circ Arrhythm Electrophysiol. 2012;5(2):302–311. doi: 10.1161/CIRCEP.111.964916. PubMed DOI

Di Biase L, et al. Periprocedural stroke and management of major bleeding complications in patients undergoing catheter ablation of atrial fibrillation: the impact of periprocedural therapeutic international normalized ratio. Circulation. 2010;121(23):2550–2556. doi: 10.1161/CIRCULATIONAHA.109.921320. PubMed DOI

Wazni OM, et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratio: comparison of strategies of anticoagulation management in the periprocedural period. Circulation. 2007;116(22):2531–2534. doi: 10.1161/CIRCULATIONAHA.107.727784. PubMed DOI

Schmidt M, et al. Atrial fibrillation ablation in patients with therapeutic international normalized ratios. Pacing Clin Electrophysiol. 2009;32(8):995–999. doi: 10.1111/j.1540-8159.2009.02429.x. PubMed DOI

Hakalahti A, et al. Catheter ablation of atrial fibrillation in patients with therapeutic oral anticoagulation treatment. Europace. 2011;13(5):640–645. doi: 10.1093/europace/eur038. PubMed DOI

Di Biase L, et al. Periprocedural stroke and bleeding complications in patients undergoing catheter ablation of atrial fibrillation with different anticoagulation management: results from the role of Coumadin in preventing thromboembolism in atrial fibrillation (AF) patients undergoing catheter ablation (COMPARE) randomized trial. Circulation. 2014;129(25):2638–2644. doi: 10.1161/CIRCULATIONAHA.113.006426. PubMed DOI

Hohnloser SH, Camm AJ. Safety and efficacy of dabigatran etexilate during catheter ablation of atrial fibrillation: a meta-analysis of the literature. Europace. 2013;15(10):1407–1411. doi: 10.1093/europace/eut241. PubMed DOI

Calkins H, et al. RE-CIRCUIT study-randomized evaluation of dabigatran etexilate compared to warfarin in pulmonary vein ablation: assessment of an uninterrupted periprocedural anticoagulation strategy. Am J Cardiol. 2015;115(1):154–155. doi: 10.1016/j.amjcard.2014.10.002. PubMed DOI

Cappato R, et al. Uninterrupted rivaroxaban vs. uninterrupted vitamin K antagonists for catheter ablation in non-valvular atrial fibrillation. Eur Heart J. 2015;36(28):1805–1811. doi: 10.1093/eurheartj/ehv177. PubMed DOI PMC

Di Biase L, et al. Feasibility and safety of uninterrupted periprocedural apixaban administration in patients undergoing radiofrequency catheter ablation for atrial fibrillation: results from a multicenter study. Heart Rhythm. 2015;12(6):1162–1168. doi: 10.1016/j.hrthm.2015.02.028. PubMed DOI

Bassiouny M, et al. Use of dabigatran for periprocedural anticoagulation in patients undergoing catheter ablation for atrial fibrillation. Circ Arrhythm Electrophysiol. 2013;6(3):460–466. doi: 10.1161/CIRCEP.113.000320. PubMed DOI PMC

Bin Abdulhak AA, et al. Safety and efficacy of interrupted dabigatran for peri-procedural anticoagulation in catheter ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 2013;15(10):1412–1420. doi: 10.1093/europace/eut239. PubMed DOI

Providencia R, et al. Rivaroxaban and dabigatran in patients undergoing catheter ablation of atrial fibrillation. Europace. 2014;16(8):1137–1144. doi: 10.1093/europace/euu007. PubMed DOI

Winkle RA, et al. Peri-procedural interrupted oral anticoagulation for atrial fibrillation ablation: comparison of aspirin, warfarin, dabigatran, and rivaroxaban. Europace. 2014;16(10):1443–1449. doi: 10.1093/europace/euu196. PubMed DOI PMC

Armbruster HL, et al. Safety of novel oral anticoagulants compared with uninterrupted warfarin for catheter ablation of atrial fibrillation. Ann Pharmacother. 2015;49(3):278–284. doi: 10.1177/1060028014563950. PubMed DOI

Ren JF, Marchlinski FE, Callans DJ. Left atrial thrombus associated with ablation for atrial fibrillation: identification with intracardiac echocardiography. J Am Coll Cardiol. 2004;43(10):1861–1867. doi: 10.1016/j.jacc.2004.01.031. PubMed DOI

Saksena S, et al. A prospective comparison of cardiac imaging using intracardiac echocardiography with transesophageal echocardiography in patients with atrial fibrillation: the intracardiac echocardiography guided cardioversion helps interventional procedures study. Circ Arrhythm Electrophysiol. 2010;3(6):571–577. doi: 10.1161/CIRCEP.110.936161. PubMed DOI

Baran J, et al. Intracardiac echocardiography for detection of thrombus in the left atrial appendage: comparison with transesophageal echocardiography in patients undergoing ablation for atrial fibrillation: the action-ice I study. Circ Arrhythm Electrophysiol. 2013;6(6):1074–1081. doi: 10.1161/CIRCEP.113.000504. PubMed DOI

Ren JF, et al. Intracardiac echocardiographic diagnosis of thrombus formation in the left atrial appendage: a complementary role to transesophageal echocardiography. Echocardiography. 2013;30(1):72–80. doi: 10.1111/j.1540-8175.2012.01819.x. PubMed DOI

Anter E, et al. Comparison of intracardiac echocardiography and transesophageal echocardiography for imaging of the right and left atrial appendages. Heart Rhythm. 2014;11(11):1890–1897. doi: 10.1016/j.hrthm.2014.07.015. PubMed DOI

Sriram CS, et al. Detection of left atrial thrombus by intracardiac echocardiography in patients undergoing ablation of atrial fibrillation. J Interv Card Electrophysiol. 2015;43(3):227–236. doi: 10.1007/s10840-015-0008-2. PubMed DOI

Maleki K, et al. Intracardiac ultrasound detection of thrombus on transseptal sheath: incidence, treatment, and prevention. J Cardiovasc Electrophysiol. 2005;16(6):561–565. doi: 10.1111/j.1540-8167.2005.40686.x. PubMed DOI

Wazni OM, et al. Embolic events and char formation during pulmonary vein isolation in patients with atrial fibrillation: impact of different anticoagulation regimens and importance of intracardiac echo imaging. J Cardiovasc Electrophysiol. 2005;16(6):576–581. doi: 10.1111/j.1540-8167.2005.40480.x. PubMed DOI

Shah D. Filamentous thrombi during left-sided sheath-assisted catheter ablations. Europace. 2010;12(12):1657–1658. doi: 10.1093/europace/euq257. PubMed DOI

Ren JF, et al. Increased intensity of anticoagulation may reduce risk of thrombus during atrial fibrillation ablation procedures in patients with spontaneous echo contrast. J Cardiovasc Electrophysiol. 2005;16(5):474–477. doi: 10.1046/j.1540-8167.2005.40465.x. PubMed DOI

Bruce CJ, et al. Early heparinization decreases the incidence of left atrial thrombi detected by intracardiac echocardiography during radiofrequency ablation for atrial fibrillation. J Interv Card Electrophysiol. 2008;22(3):211–219. doi: 10.1007/s10840-008-9270-x. PubMed DOI

Asbach S, et al. Early heparin administration reduces risk for left atrial thrombus formation during atrial fibrillation ablation procedures. Cardiol Res Pract. 2011;2011:615087. doi: 10.4061/2011/615087. PubMed DOI PMC

Briceno DF, et al. Clinical impact of heparin kinetics during catheter ablation of atrial fibrillation: meta-analysis and meta-regression. J Cardiovasc Electrophysiol. 2016;27(6):683–693. doi: 10.1111/jce.12975. PubMed DOI

Chilukuri K, et al. Incidence and outcomes of protamine reactions in patients undergoing catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2009;25(3):175–181. doi: 10.1007/s10840-009-9364-0. PubMed DOI

Thygesen K, et al. Universal definition of myocardial infarction. J Am Coll Cardiol. 2007;50(22):2173–2195. doi: 10.1016/j.jacc.2007.09.011. PubMed DOI

Helps SC, et al. The effect of gas emboli on rabbit cerebral blood flow. Stroke. 1990;21(1):94–99. doi: 10.1161/01.STR.21.1.94. PubMed DOI

Krivonyak GS, Warren SG. Cerebral arterial air embolism treated by a vertical head-down maneuver. Catheter Cardiovasc Interv. 2000;49(2):185–187. doi: 10.1002/(SICI)1522-726X(200002)49:2<185::AID-CCD15>3.0.CO;2-C. PubMed DOI

Cauchemez B, et al. High-flow perfusion of sheaths for prevention of thromboembolic complications during complex catheter ablation in the LA. J Cardiovasc Electrophysiol. 2004;15(3):276–283. doi: 10.1046/j.1540-8167.2004.03401.x. PubMed DOI

Kuwahara T, et al. Clinical characteristics of massive air embolism complicating left atrial ablation of atrial fibrillation: lessons from five cases. Europace. 2012;14(2):204–208. doi: 10.1093/europace/eur314. PubMed DOI

Franzen OW, et al. Mechanisms underlying air aspiration in patients undergoing left atrial catheterization. Catheter Cardiovasc Interv. 2008;71(4):553–558. doi: 10.1002/ccd.21445. PubMed DOI

Ryu KH, et al. Heparin reduces neurological impairment after cerebral arterial air embolism in the rabbit. Stroke. 1996;27(2):303–309. doi: 10.1161/01.STR.27.2.303. PubMed DOI

Gaita F, et al. Incidence of silent cerebral thromboembolic lesions after atrial fibrillation ablation may change according to technology used: comparison of irrigated radiofrequency, multipolar nonirrigated catheter and cryoballoon. J Cardiovasc Electrophysiol. 2011;22(9):961–968. doi: 10.1111/j.1540-8167.2011.02050.x. PubMed DOI

Herrera Siklody C, et al. Incidence of asymptomatic intracranial embolic events after pulmonary vein isolation: comparison of different atrial fibrillation ablation technologies in a multicenter study. J Am Coll Cardiol. 2011;58(7):681–688. doi: 10.1016/j.jacc.2011.04.010. PubMed DOI

Verma A, et al. Evaluation and reduction of asymptomatic cerebral embolism in ablation of atrial fibrillation, but high prevalence of chronic silent infarction: results of the evaluation of reduction of asymptomatic cerebral embolism trial. Circ Arrhythm Electrophysiol. 2013;6(5):835–842. doi: 10.1161/CIRCEP.113.000612. PubMed DOI

De Greef Y, et al. Low rate of asymptomatic cerebral embolism and improved procedural efficiency with the novel pulmonary vein ablation catheter GOLD: results of the PRECISION GOLD trial. Europace. 2016;18(5):687–695. doi: 10.1093/europace/euv385. PubMed DOI PMC

Deneke T, et al. Silent cerebral events/lesions related to atrial fibrillation ablation: a clinical review. J Cardiovasc Electrophysiol. 2015;26(4):455–463. doi: 10.1111/jce.12608. PubMed DOI

Merchant FM, Delurgio DB. Catheter ablation of atrial fibrillation and risk of asymptomatic cerebral embolism. Pacing Clin Electrophysiol. 2014;37(3):389–397. doi: 10.1111/pace.12336. PubMed DOI

Lickfett L, et al. Cerebral diffusion-weighted magnetic resonance imaging: a tool to monitor the thrombogenicity of left atrial catheter ablation. J Cardiovasc Electrophysiol. 2006;17(1):1–7. PubMed

Gaita F, et al. Radiofrequency catheter ablation of atrial fibrillation: a cause of silent thromboembolism? Magnetic resonance imaging assessment of cerebral thromboembolism in patients undergoing ablation of atrial fibrillation. Circulation. 2010;122(17):1667–1673. doi: 10.1161/CIRCULATIONAHA.110.937953. PubMed DOI

Schrickel JW, et al. Incidence and predictors of silent cerebral embolism during pulmonary vein catheter ablation for atrial fibrillation. Europace. 2010;12(1):52–57. doi: 10.1093/europace/eup350. PubMed DOI

Deneke T, et al. Postablation asymptomatic cerebral lesions: long-term follow-up using magnetic resonance imaging. Heart Rhythm. 2011;8(11):1705–1711. doi: 10.1016/j.hrthm.2011.06.030. PubMed DOI

Sauren LD, et al. Transcranial measurement of cerebral microembolic signals during endocardial pulmonary vein isolation: comparison of three different ablation techniques. J Cardiovasc Electrophysiol. 2009;20(10):1102–1107. doi: 10.1111/j.1540-8167.2009.01509.x. PubMed DOI

Wieczorek M, et al. Investigation into causes of abnormal cerebral MRI findings following PVAC duty-cycled, phased RF ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2013;24(2):121–128. doi: 10.1111/jce.12006. PubMed DOI

Bendszus M, Stoll G. Silent cerebral ischaemia: hidden fingerprints of invasive medical procedures. Lancet Neurol. 2006;5(4):364–372. doi: 10.1016/S1474-4422(06)70412-4. PubMed DOI

Kruis RW, Vlasveld FA, Van Dijk D. The (un)importance of cerebral microemboli. Semin Cardiothorac Vasc Anesth. 2010;14(2):111–118. doi: 10.1177/1089253210370903. PubMed DOI

Medi C, et al. Subtle post-procedural cognitive dysfunction after atrial fibrillation ablation. J Am Coll Cardiol. 2013;62(6):531–539. doi: 10.1016/j.jacc.2013.03.073. PubMed DOI

Ichiki H, et al. The incidence of asymptomatic cerebral microthromboembolism after atrial fibrillation ablation: comparison of warfarin and dabigatran. Pacing Clin Electrophysiol. 2013;36(11):1328–1335. doi: 10.1111/pace.12195. PubMed DOI

Nagy-Balo E, et al. Transcranial measurement of cerebral microembolic signals during pulmonary vein isolation: a comparison of two ablation techniques. Circ Arrhythm Electrophysiol. 2013;6(3):473–480. doi: 10.1161/CIRCEP.112.971747. PubMed DOI

Vermeer SE, et al. Silent brain infarcts and the risk of dementia and cognitive decline. N Engl J Med. 2003;348(13):1215–1222. doi: 10.1056/NEJMoa022066. PubMed DOI

Neven K, et al. Fatal end of a safety algorithm for pulmonary vein isolation with use of high-intensity focused ultrasound. Circ Arrhythm Electrophysiol. 2010;3(3):260–265. doi: 10.1161/CIRCEP.109.922930. PubMed DOI

Ripley KL, et al. Time course of esophageal lesions after catheter ablation with cryothermal and radiofrequency ablation: implication for atrio-esophageal fistula formation after catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2007;18(6):642–646. doi: 10.1111/j.1540-8167.2007.00790.x. PubMed DOI

Ahmed H, et al. The esophageal effects of cryoenergy during cryoablation for atrial fibrillation. Heart Rhythm. 2009;6(7):962–969. doi: 10.1016/j.hrthm.2009.03.051. PubMed DOI

Kawasaki R, et al. Atrioesophageal fistula complicating cryoballoon pulmonary vein isolation for paroxysmal atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(7):787–792. doi: 10.1111/jce.12426. PubMed DOI

Lim HW, et al. Atrioesophageal fistula during cryoballoon ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2014;25(2):208–213. doi: 10.1111/jce.12313. PubMed DOI

Yokoyama K, et al. Canine model of esophageal injury and atrial-esophageal fistula after applications of forward-firing high-intensity focused ultrasound and side-firing unfocused ultrasound in the left atrium and inside the pulmonary vein. Circ Arrhythm Electrophysiol. 2009;2(1):41–49. doi: 10.1161/CIRCEP.108.807925. PubMed DOI

Singh SM, et al. Esophageal injury and temperature monitoring during atrial fibrillation ablation. Circ Arrhythm Electrophysiol. 2008;1(3):162–168. doi: 10.1161/CIRCEP.108.789552. PubMed DOI

Kuwahara T, et al. Safe and effective ablation of atrial fibrillation: importance of esophageal temperature monitoring to avoid periesophageal nerve injury as a complication of pulmonary vein isolation. J Cardiovasc Electrophysiol. 2009;20(1):1–6. doi: 10.1111/j.1540-8167.2008.01280.x. PubMed DOI

Contreras-Valdes FM, et al. Severity of esophageal injury predicts time to healing after radiofrequency catheter ablation for atrial fibrillation. Heart Rhythm. 2011;8(12):1862–1868. doi: 10.1016/j.hrthm.2011.07.022. PubMed DOI

Leite LR, et al. Luminal esophageal temperature monitoring with a deflectable esophageal temperature probe and intracardiac echocardiography may reduce esophageal injury during atrial fibrillation ablation procedures: results of a pilot study. Circ Arrhythm Electrophysiol. 2011;4(2):149–156. doi: 10.1161/CIRCEP.110.960328. PubMed DOI

Tschabrunn CM, et al. Comparison between single- and multi-sensor oesophageal temperature probes during atrial fibrillation ablation: thermodynamic characteristics. Europace. 2015;17(6):891–897. doi: 10.1093/europace/euu356. PubMed DOI

Deneke T, et al. Utility of esophageal temperature monitoring during pulmonary vein isolation for atrial fibrillation using duty-cycled phased radiofrequency ablation. J Cardiovasc Electrophysiol. 2011;22(3):255–261. doi: 10.1111/j.1540-8167.2010.01916.x. PubMed DOI

Carroll BJ, et al. Multi-sensor esophageal temperature probe used during radiofrequency ablation for atrial fibrillation is associated with increased intraluminal temperature detection and increased risk of esophageal injury compared to single-sensor probe. J Cardiovasc Electrophysiol. 2013;24(9):958–964. doi: 10.1111/jce.12180. PubMed DOI

Muller P, et al. Higher incidence of esophageal lesions after ablation of atrial fibrillation related to the use of esophageal temperature probes. Heart Rhythm. 2015;12(7):1464–1469. doi: 10.1016/j.hrthm.2015.04.005. PubMed DOI

Tsuchiya T, et al. Atrial fibrillation ablation with esophageal cooling with a cooled water-irrigated intraesophageal balloon: a pilot study. J Cardiovasc Electrophysiol. 2007;18(2):145–150. doi: 10.1111/j.1540-8167.2006.00693.x. PubMed DOI

Arruda MS, et al. Feasibility and safety of using an esophageal protective system to eliminate esophageal thermal injury: implications on atrial-esophageal fistula following AF ablation. J Cardiovasc Electrophysiol. 2009;20(11):1272–1278. doi: 10.1111/j.1540-8167.2009.01536.x. PubMed DOI

Kuwahara T, et al. Oesophageal cooling with ice water does not reduce the incidence of oesophageal lesions complicating catheter ablation of atrial fibrillation: randomized controlled study. Europace. 2014;16(6):834–839. doi: 10.1093/europace/eut368. PubMed DOI

Kuwahara T, et al. Incidences of esophageal injury during esophageal temperature monitoring: a comparative study of a multi-thermocouple temperature probe and a deflectable temperature probe in atrial fibrillation ablation. J Interv Card Electrophysiol. 2014;39(3):251–257. doi: 10.1007/s10840-013-9868-5. PubMed DOI

Chugh A, et al. Mechanical displacement of the esophagus in patients undergoing left atrial ablation of atrial fibrillation. Heart Rhythm. 2009;6(3):319–322. doi: 10.1016/j.hrthm.2008.12.010. PubMed DOI

Koruth JS, et al. Mechanical esophageal displacement during catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2012;23(2):147–154. doi: 10.1111/j.1540-8167.2011.02162.x. PubMed DOI

Zellerhoff S, Lenze F, Eckardt L. Prophylactic proton pump inhibition after atrial fibrillation ablation: is there any evidence? Europace. 2011;13(9):1219–1221. doi: 10.1093/europace/eur139. PubMed DOI

Zellerhoff S, et al. Fatal course of esophageal stenting of an atrioesophageal fistula after atrial fibrillation ablation. Heart Rhythm. 2011;8(4):624–626. doi: 10.1016/j.hrthm.2010.10.041. PubMed DOI

Khan M, et al. Medical treatments in the short term management of reflux oesophagitis. Cochrane Database Syst Rev. 2007;2:CD003244. PubMed

Kahrilas PJ. Clinical practice. Gastroesophageal reflux disease. N Engl J Med. 2008;359(16):1700–1707. doi: 10.1056/NEJMcp0804684. PubMed DOI PMC

Shaheen NJ, et al. Pantoprazole reduces the size of postbanding ulcers after variceal band ligation: a randomized, controlled trial. Hepatology. 2005;41(3):588–594. doi: 10.1002/hep.20593. PubMed DOI

Halm U, et al. Thermal esophageal lesions after radiofrequency catheter ablation of left atrial arrhythmias. Am J Gastroenterol. 2010;105(3):551–556. doi: 10.1038/ajg.2009.625. PubMed DOI

Knopp H, et al. Incidental and ablation-induced findings during upper gastrointestinal endoscopy in patients after ablation of atrial fibrillation: a retrospective study of 425 patients. Heart Rhythm. 2014;11(4):574–578. doi: 10.1016/j.hrthm.2014.01.010. PubMed DOI

Dagres N, et al. Rapid detection and successful treatment of esophageal perforation after radiofrequency ablation of atrial fibrillation: lessons from five cases. J Cardiovasc Electrophysiol. 2006;17(11):1213–1215. doi: 10.1111/j.1540-8167.2006.00611.x. PubMed DOI

Eitel C, et al. Successful nonsurgical treatment of esophagopericardial fistulas after atrial fibrillation catheter ablation: a case series. Circ Arrhythm Electrophysiol. 2013;6(4):675–681. doi: 10.1161/CIRCEP.113.000384. PubMed DOI

Hazell W, et al. Atrio-oesophageal fistula: an emergent complication of radiofrequency ablation. Emerg Med Australas. 2009;21(4):329–332. doi: 10.1111/j.1742-6723.2009.01205.x. PubMed DOI

Cazavet A, et al. Successful surgery for atrioesophageal fistula caused by transcatheter ablation of atrial fibrillation. J Thorac Cardiovasc Surg. 2010;140(3):e43–e45. doi: 10.1016/j.jtcvs.2010.02.032. PubMed DOI

Podgaetz E, Deschamps C. Esophageal complications of catheter ablation for atrial fibrillation: a case report. J Thorac Cardiovasc Surg. 2013;145(1):e9–e13. doi: 10.1016/j.jtcvs.2012.10.022. PubMed DOI

Queneherve L, et al. Endoscopic management of an esophagopericardial fistula after radiofrequency ablation for atrial fibrillation. World J Gastroenterol. 2013;19(21):3352–3353. doi: 10.3748/wjg.v19.i21.3352. PubMed DOI PMC

Gunes MF, et al. Ablating the posterior heart: cardioesophageal fistula complicating radiofrequency ablation in the coronary sinus. J Cardiovasc Electrophysiol. 2015;26(12):1376–1378. doi: 10.1111/jce.12831. PubMed DOI

Qadeer MA, et al. Endoscopic clips for closing esophageal perforations: case report and pooled analysis. Gastrointest Endosc. 2007;66(3):605–611. doi: 10.1016/j.gie.2007.03.1028. PubMed DOI

Ellis CR, et al. Successful treatment of esophageal perforation following atrial fibrillation ablation with a fully covered esophageal stent: prevention of atrial-esophageal fistula. J Innov Cardiac Rhythm Management. 2012;3:874–878.

Markar SR, et al. Novel multimodality endoscopic closure of postoperative esophageal fistula. Int J Surg Case Rep. 2012;3(11):577–579. doi: 10.1016/j.ijscr.2012.08.001. PubMed DOI PMC

Andrade JG, et al. Efficacy and safety of cryoballoon ablation for atrial fibrillation: a systematic review of published studies. Heart Rhythm. 2011;8(9):1444–1451. doi: 10.1016/j.hrthm.2011.03.050. PubMed DOI

Deshmukh A, et al. In-hospital complications associated with catheter ablation of atrial fibrillation in the United States between 2000 and 2010: analysis of 93 801 procedures. Circulation. 2013;128(19):2104–2112. doi: 10.1161/CIRCULATIONAHA.113.003862. PubMed DOI

Cappato R, et al. Delayed cardiac tamponade after radiofrequency catheter ablation of atrial fibrillation: a worldwide report. J Am Coll Cardiol. 2011;58(25):2696–2697. doi: 10.1016/j.jacc.2011.09.028. PubMed DOI

Eick OJ, Gerritse B, Schumacher B. Popping phenomena in temperature-controlled radiofrequency ablation: when and why do they occur? Pacing Clin Electrophysiol. 2000;23(2):253–258. doi: 10.1111/j.1540-8159.2000.tb00807.x. PubMed DOI

Fisher JD, et al. Internal transcardiac pericardiocentesis for acute tamponade. Am J Cardiol. 2000;86(12):1388–1389. doi: 10.1016/S0002-9149(00)01252-2. PubMed DOI

Hsu LF, et al. Transcardiac pericardiocentesis: an emergency life-saving technique for cardiac tamponade. J Cardiovasc Electrophysiol. 2003;14(9):1001–1003. doi: 10.1046/j.1540-8167.2003.03153.x. PubMed DOI

Bunch TJ, et al. Outcomes after cardiac perforation during radiofrequency ablation of the atrium. J Cardiovasc Electrophysiol. 2005;16(11):1172–1179. doi: 10.1111/j.1540-8167.2005.50135.x. PubMed DOI

Hsu LF, et al. Incidence and prevention of cardiac tamponade complicating ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2005;28(Suppl 1):S106–S109. doi: 10.1111/j.1540-8159.2005.00062.x. PubMed DOI

Michowitz Y, et al. Effects of sex on the incidence of cardiac tamponade after catheter ablation of atrial fibrillation: results from a worldwide survey in 34 943 atrial fibrillation ablation procedures. Circ Arrhythm Electrophysiol. 2014;7(2):274–280. doi: 10.1161/CIRCEP.113.000760. PubMed DOI

Tsang TS, et al. Consecutive 1127 therapeutic echocardiographically guided pericardiocenteses: clinical profile, practice patterns, and outcomes spanning 21 years. Mayo Clin Proc. 2002;77(5):429–436. doi: 10.1016/S0025-6196(11)62211-8. PubMed DOI

O'Neill MD, et al. Two techniques to avoid surgery for cardiac tamponade occurring during catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19(3):323–325. doi: 10.1111/j.1540-8167.2007.00973.x. PubMed DOI

Takahashi Y, et al. Acute occlusion of the left circumflex coronary artery during mitral isthmus linear ablation. J Cardiovasc Electrophysiol. 2005;16(10):1104–1107. doi: 10.1111/j.1540-8167.2005.50124.x. PubMed DOI

Chugh A, et al. Manifestations of coronary arterial injury during catheter ablation of atrial fibrillation and related arrhythmias. Heart Rhythm. 2013;10(11):1638–1645. doi: 10.1016/j.hrthm.2013.09.001. PubMed DOI

Makimoto H, et al. Aborted sudden cardiac death due to radiofrequency ablation within the coronary sinus and subsequent total occlusion of the circumflex artery. J Cardiovasc Electrophysiol. 2013;24(8):929–932. doi: 10.1111/jce.12083. PubMed DOI

Kitamura T, et al. Transient sinus node dysfunction following sinus node artery occlusion due to radiofrequency catheter ablation of the septal superior vena cava-right atrium junction. J Electrocardiol. 2016;49(1):18–22. doi: 10.1016/j.jelectrocard.2015.11.001. PubMed DOI

Ouali S, et al. Acute coronary occlusion during radiofrequency catheter ablation of typical atrial flutter. J Cardiovasc Electrophysiol. 2002;13(10):1047–1049. doi: 10.1046/j.1540-8167.2002.01047.x. PubMed DOI

Mykytsey A, et al. Right coronary artery occlusion during RF ablation of typical atrial flutter. J Cardiovasc Electrophysiol. 2010;21(7):818–821. PubMed

Sticherling C, Pfister O, Osswald S. Thrombo-embolic occlusion of the left anterior descending coronary artery complicating left atrial radiofrequency ablation. Europace. 2009;11(1):117–118. doi: 10.1093/europace/eun300. PubMed DOI

Wong KC, et al. High incidence of acute sub-clinical circumflex artery ‘injury’ following mitral isthmus ablation. Eur Heart J. 2011;32(15):1881–1890. doi: 10.1093/eurheartj/ehr117. PubMed DOI

Fayad G, et al. Circumflex artery stenosis induced by intraoperative radiofrequency ablation. Ann Thorac Surg. 2003;76(4):1291–1293. doi: 10.1016/S0003-4975(03)00476-4. PubMed DOI

Piccini JP, et al. Outcomes of Medicare beneficiaries undergoing catheter ablation for atrial fibrillation. Circulation. 2012;126(18):2200–2207. doi: 10.1161/CIRCULATIONAHA.112.109330. PubMed DOI PMC

Lakkireddy D, et al. Effect of atrial fibrillation ablation on gastric motility: the atrial fibrillation gut study. Circ Arrhythm Electrophysiol. 2015;8(3):531–536. doi: 10.1161/CIRCEP.114.002508. PubMed DOI

Dumonceau JM, et al. Acute delayed gastric emptying after ablation of atrial fibrillation: treatment with botulinum toxin injection. Endoscopy. 2006;38(5):543. doi: 10.1055/s-2006-925323. PubMed DOI

Bunch TJ, et al. Vagus nerve injury after posterior atrial radiofrequency ablation. Heart Rhythm. 2008;5(9):1327–1330. doi: 10.1016/j.hrthm.2008.05.014. PubMed DOI

Kuwahara T, et al. Clinical characteristics and management of periesophageal vagal nerve injury complicating left atrial ablation of atrial fibrillation: lessons from eleven cases. J Cardiovasc Electrophysiol. 2013;24(8):847–851. doi: 10.1111/jce.12130. PubMed DOI

Miyazaki S, et al. Factors associated with periesophageal vagal nerve injury after pulmonary vein antrum isolation. J Am Heart Assoc. 2014;3(5):e001209. doi: 10.1161/JAHA.114.001209. PubMed DOI PMC

Chopra N, Shadchehr A. Achalasia cardia as a unique complication of pulmonary vein isolation. Heart Rhythm. 2014;11(12):2297–2299. doi: 10.1016/j.hrthm.2014.08.010. PubMed DOI

Schwartz TW, et al. Pancreatic-polypeptide response to food in duodenal-ulcer patients before and after vagotomy. Lancet. 1976;1(7969):1102–1105. doi: 10.1016/S0140-6736(76)90065-9. PubMed DOI

Ajaj W, et al. Real time high resolution magnetic resonance imaging for the assessment of gastric motility disorders. Gut. 2004;53(9):1256–1261. doi: 10.1136/gut.2003.038588. PubMed DOI PMC

Pisani CF, et al. Gastric hypomotility following epicardial vagal denervation ablation to treat atrial fibrillation. J Cardiovasc Electrophysiol. 2008;19(2):211–213. doi: 10.1111/j.1540-8167.2007.00937.x. PubMed DOI

Kanaeda T, et al. Evaluation of periesophageal nerve injury after pulmonary vein isolation using the (13)C-acetate breath test. J Arrhythm. 2015;31(6):364–370. doi: 10.1016/j.joa.2015.06.004. PubMed DOI PMC

Lo LW, et al. A novel finding—impairment of gastric myoelectricity after catheter ablation of atrial fibrillation. Circ J. 2013;77(8):2014–2023. doi: 10.1253/circj.CJ-13-0014. PubMed DOI

Janssens J, et al. Improvement of gastric emptying in diabetic gastroparesis by erythromycin. Preliminary studies. N Engl J Med. 1990;322(15):1028–1031. doi: 10.1056/NEJM199004123221502. PubMed DOI

Jones MP, Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol. 2003;98(10):2122–2129. doi: 10.1111/j.1572-0241.2003.07721.x. PubMed DOI

Tavernier R, Duytschaever M, Taeymans Y. Fracture of a circular mapping catheter after entrapment in the mitral valve apparatus during segmental pulmonary vein isolation. Pacing Clin Electrophysiol. 2003;26(8):1774–1775. doi: 10.1046/j.1460-9592.2003.t01-1-00268.x. PubMed DOI

Grove R, et al. Demand for open heart surgery due to entrapment of a circular mapping catheter in the mitral valve in a patient undergoing atrial fibrillation ablation. Clin Res Cardiol. 2008;97(9):628–629. doi: 10.1007/s00392-008-0677-2. PubMed DOI

Lakkireddy D, et al. Radiofrequency ablation of atrial fibrillation in patients with mitral or aortic mechanical prosthetic valves: a feasibility, safety, and efficacy study. Heart Rhythm. 2011;8(7):975–980. doi: 10.1016/j.hrthm.2011.02.012. PubMed DOI

Zeljko HM, et al. Entrapment of the circular mapping catheter in the mitral valve in two patients undergoing atrial fibrillation ablation. Europace. 2011;13(1):132–133. doi: 10.1093/europace/euq309. PubMed DOI

Desimone CV, et al. Catheter ablation related mitral valve injury: the importance of early recognition and rescue mitral valve repair. J Cardiovasc Electrophysiol. 2014;25(9):971–975. doi: 10.1111/jce.12439. PubMed DOI PMC

Gurbuz O, et al. Case report: paravalvular leak as a complication of percutaneous catheter ablation for atrial fibrillation. J Cardiothorac Surg. 2014;9:187. doi: 10.1186/s13019-014-0187-4. PubMed DOI PMC

Mansour M, et al. Successful release of entrapped circumferential mapping catheters in patients undergoing pulmonary vein isolation for atrial fibrillation. Heart Rhythm. 2004;1(5):558–561. doi: 10.1016/j.hrthm.2004.07.004. PubMed DOI

Wu RC, et al. Circular mapping catheter entrapment in the mitral valve apparatus: a previously unrecognized complication of focal atrial fibrillation ablation. J Cardiovasc Electrophysiol. 2002;13(8):819–821. doi: 10.1046/j.1540-8167.2002.00819.x. PubMed DOI

Deftereos S, et al. Colchicine for prevention of early atrial fibrillation recurrence after pulmonary vein isolation: a randomized controlled study. J Am Coll Cardiol. 2012;60(18):1790–1796. doi: 10.1016/j.jacc.2012.07.031. PubMed DOI

Deftereos S, et al. Colchicine for prevention of atrial fibrillation recurrence after pulmonary vein isolation: mid-term efficacy and effect on quality of life. Heart Rhythm. 2014;11(4):620–628. doi: 10.1016/j.hrthm.2014.02.002. PubMed DOI

Stabile G, et al. Low incidence of permanent complications during catheter ablation for atrial fibrillation using open-irrigated catheters: a multicentre registry. Europace. 2014;16(8):1154–1159. doi: 10.1093/europace/euu002. PubMed DOI

Luckie M, et al. Dressler's syndrome following pulmonary vein isolation for atrial fibrillation. Acute Card Care. 2008;10(4):234–235. doi: 10.1080/17482940701843722. PubMed DOI

Lambert T, et al. Cardiac tamponade following pericarditis 18 days after catheter ablation of atrial fibrillation. Clin Res Cardiol. 2010;99(9):595–597. doi: 10.1007/s00392-010-0174-2. PubMed DOI

Torihashi S, et al. Two cases of delayed cardiac tamponade due to pericarditis after pulmonary vein (PV) isolation for atrial fibrillation. Intern Med. 2015;54(7):791–796. doi: 10.2169/internalmedicine.54.2537. PubMed DOI

Kim DR, et al. Comparison of two different doses of single bolus steroid injection to prevent atrial fibrillation recurrence after radiofrequency catheter ablation. Yonsei Med J. 2015;56(2):324–331. doi: 10.3349/ymj.2015.56.2.324. PubMed DOI PMC

Kesek M, et al. Entrapment of circular mapping catheter in the mitral valve. Heart Rhythm. 2007;4(1):17–19. doi: 10.1016/j.hrthm.2006.09.016. PubMed DOI

Kuck KH, et al. Cryoballoon or radiofrequency ablation for symptomatic paroxysmal atrial fibrillation: reintervention, rehospitalization, and quality-of-life outcomes in the FIRE AND ICE trial. Eur Heart J. 2016;37(38):2858–2865. doi: 10.1093/eurheartj/ehw285. PubMed DOI PMC

Sohara H, et al. Feasibility of the radiofrequency hot balloon catheter for isolation of the posterior left atrium and pulmonary veins for the treatment of atrial fibrillation. Circ Arrhythm Electrophysiol. 2009;2(3):225–232. doi: 10.1161/CIRCEP.108.817205. PubMed DOI

Evonich RF, Nori DM, Haines DE. Efficacy of pulmonary vein isolation with a novel hot balloon ablation catheter. J Interv Card Electrophysiol. 2012;34(1):29–36. doi: 10.1007/s10840-011-9646-1. PubMed DOI

Chun KR, et al. The ‘single big cryoballoon’ technique for acute pulmonary vein isolation in patients with paroxysmal atrial fibrillation: a prospective observational single centre study. Eur Heart J. 2009;30(6):699–709. doi: 10.1093/eurheartj/ehn570. PubMed DOI PMC

Hoyt H, et al. Complications arising from catheter ablation of atrial fibrillation: temporal trends and predictors. Heart Rhythm. 2011;8(12):1869–1874. doi: 10.1016/j.hrthm.2011.07.025. PubMed DOI

Guhl EN, et al. Efficacy of cryoballoon pulmonary vein isolation in patients with persistent atrial fibrillation. J Cardiovasc Electrophysiol. 2016;27(4):423–427. doi: 10.1111/jce.12924. PubMed DOI

Earley MJ, et al. Radiofrequency ablation of arrhythmias guided by non-fluoroscopic catheter location: a prospective randomized trial. Eur Heart J. 2006;27(10):1223–1229. doi: 10.1093/eurheartj/ehi834. PubMed DOI

Sarabanda AV, et al. Efficacy and safety of circumferential pulmonary vein isolation using a novel cryothermal balloon ablation system. J Am Coll Cardiol. 2005;46(10):1902–1912. doi: 10.1016/j.jacc.2005.07.046. PubMed DOI

Guiot A, et al. Collateral nervous damages after cryoballoon pulmonary vein isolation. J Cardiovasc Electrophysiol. 2012;23(4):346–351. doi: 10.1111/j.1540-8167.2011.02219.x. PubMed DOI

Metzner A, et al. The incidence of phrenic nerve injury during pulmonary vein isolation using the second-generation 28 mm cryoballoon. J Cardiovasc Electrophysiol. 2014;25(5):466–470. doi: 10.1111/jce.12358. PubMed DOI

Okumura Y, et al. Distortion of right superior pulmonary vein anatomy by balloon catheters as a contributor to phrenic nerve injury. J Cardiovasc Electrophysiol. 2009;20(10):1151–1157. doi: 10.1111/j.1540-8167.2009.01495.x. PubMed DOI

Arruda M, et al. Electrical isolation of the superior vena cava: an adjunctive strategy to pulmonary vein antrum isolation improving the outcome of AF ablation. J Cardiovasc Electrophysiol. 2007;18(12):1261–1266. doi: 10.1111/j.1540-8167.2007.00953.x. PubMed DOI

Miyazaki S, et al. Prevalence and clinical outcome of phrenic nerve injury during superior vena cava isolation and circumferential pulmonary vein antrum isolation using radiofrequency energy. Am Heart J. 2014;168(6):846–853. doi: 10.1016/j.ahj.2014.09.011. PubMed DOI

Wissner E, et al. Catheter ablation of atrial fibrillation in patients with persistent left superior vena cava is associated with major intraprocedural complications. Heart Rhythm. 2010;7(12):1755–1760. doi: 10.1016/j.hrthm.2010.08.005. PubMed DOI

Elayi CS, et al. Left superior vena cava isolation in patients undergoing pulmonary vein antrum isolation: impact on atrial fibrillation recurrence. Heart Rhythm. 2006;3(9):1019–1023. doi: 10.1016/j.hrthm.2006.05.024. PubMed DOI

Liu H, et al. Electrogram-guided isolation of the left superior vena cava for treatment of atrial fibrillation. Europace. 2007;9(9):775–780. doi: 10.1093/europace/eum118. PubMed DOI

Yong Ji S, et al. Phrenic nerve injury: an underrecognized and potentially preventable complication of pulmonary vein isolation using a wide-area circumferential ablation approach. J Cardiovasc Electrophysiol. 2013;24(10):1086–1091. PubMed

Franceschi F, et al. Phrenic nerve monitoring with diaphragmatic electromyography during cryoballoon ablation for atrial fibrillation: the first human application. Heart Rhythm. 2011;8(7):1068–1071. doi: 10.1016/j.hrthm.2011.01.047. PubMed DOI

Miyazaki S, et al. Prospective evaluation of bilateral diaphragmatic electromyograms during cryoballoon ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2015;26(6):622–628. doi: 10.1111/jce.12671. PubMed DOI

Mondesert B, et al. Clinical experience with a novel electromyographic approach to preventing phrenic nerve injury during cryoballoon ablation in atrial fibrillation. Circ Arrhythm Electrophysiol. 2014;7(4):605–611. doi: 10.1161/CIRCEP.113.001238. PubMed DOI

Sacher F, et al. Phrenic nerve injury after atrial fibrillation catheter ablation: characterization and outcome in a multicenter study. J Am Coll Cardiol. 2006;47(12):2498–2503. doi: 10.1016/j.jacc.2006.02.050. PubMed DOI

Andrade JG, et al. Histopathology of cryoballoon ablation-induced phrenic nerve injury. J Cardiovasc Electrophysiol. 2014;25(2):187–194. doi: 10.1111/jce.12296. PubMed DOI

Pappone C, et al. Circumferential radiofrequency ablation of pulmonary vein ostia: a new anatomic approach for curing atrial fibrillation. Circulation. 2000;102(21):2619–2628. doi: 10.1161/01.CIR.102.21.2619. PubMed DOI

Dukkipati SR, et al. Pulmonary vein isolation using a visually guided laser balloon catheter: the first 200-patient multicenter clinical experience. Circ Arrhythm Electrophysiol. 2013;6(3):467–472. doi: 10.1161/CIRCEP.113.000431. PubMed DOI

Katz ES, et al. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol. 2000;36(2):468–471. doi: 10.1016/S0735-1097(00)00765-8. PubMed DOI

Caponi D, et al. Ablation of atrial fibrillation: does the addition of three-dimensional magnetic resonance imaging of the left atrium to electroanatomic mapping improve the clinical outcome? A randomized comparison of Carto-merge vs. Carto-XP three-dimensional mapping ablation in patients with paroxysmal and persistent atrial fibrillation. Europace. 2010;12(8):1098–1104. doi: 10.1093/europace/euq107. PubMed DOI

Proietti R, et al. Remote magnetic with open-irrigated catheter vs. manual navigation for ablation of atrial fibrillation: a systematic review and meta-analysis. Europace. 2013;15(9):1241–1248. doi: 10.1093/europace/eut058. PubMed DOI

Ferguson JD, et al. Catheter ablation of atrial fibrillation without fluoroscopy using intracardiac echocardiography and electroanatomic mapping. Circ Arrhythm Electrophysiol. 2009;2(6):611–619. doi: 10.1161/CIRCEP.109.872093. PubMed DOI PMC

Calkins H, et al. Radiation exposure during radiofrequency catheter ablation of accessory atrioventricular connections. Circulation. 1991;84(6):2376–2382. doi: 10.1161/01.CIR.84.6.2376. PubMed DOI

Lindsay BD, et al. Radiation exposure to patients and medical personnel during radiofrequency catheter ablation for supraventricular tachycardia. Am J Cardiol. 1992;70(2):218–223. doi: 10.1016/0002-9149(92)91278-C. PubMed DOI

Kovoor P, et al. Risk to patients from radiation associated with radiofrequency ablation for supraventricular tachycardia. Circulation. 1998;98(15):1534–1540. doi: 10.1161/01.CIR.98.15.1534. PubMed DOI

Macle L, et al. Radiation exposure during radiofrequency catheter ablation for atrial fibrillation. Pacing Clin Electrophysiol. 2003;26(1 Pt 2):288–291. doi: 10.1046/j.1460-9592.2003.00034.x. PubMed DOI

Lickfett L, et al. Radiation exposure during catheter ablation of atrial fibrillation. Circulation. 2004;110(19):3003–3010. doi: 10.1161/01.CIR.0000146952.49223.11. PubMed DOI

Ector J, et al. Obesity is a major determinant of radiation dose in patients undergoing pulmonary vein isolation for atrial fibrillation. J Am Coll Cardiol. 2007;50(3):234–242. doi: 10.1016/j.jacc.2007.03.040. PubMed DOI

Chen J, et al. Cumulative exposure to ionizing radiation from diagnostic and therapeutic cardiac imaging procedures: a population-based analysis. J Am Coll Cardiol. 2010;56(9):702–711. doi: 10.1016/j.jacc.2010.05.014. PubMed DOI PMC

Khaykin Y, et al. CARTO-guided vs. NavX-guided pulmonary vein antrum isolation and pulmonary vein antrum isolation performed without 3-D mapping: effect of the 3-D mapping system on procedure duration and fluoroscopy time. J Interv Card Electrophysiol. 2011;30(3):233–240. doi: 10.1007/s10840-010-9538-9. PubMed DOI

Stabile G, et al. Reduced fluoroscopy exposure during ablation of atrial fibrillation using a novel electroanatomical navigation system: a multicentre experience. Europace. 2012;14(1):60–65. doi: 10.1093/europace/eur271. PubMed DOI

De Ponti R, et al. Simulator training reduces radiation exposure and improves trainees’ performance in placing electrophysiologic catheters during patient-based procedures. Heart Rhythm. 2012;9(8):1280–1285. doi: 10.1016/j.hrthm.2012.04.015. PubMed DOI

Kleemann T, et al. Development of radiation exposure in patients undergoing pulmonary vein isolation in Germany between 2007 and 2014: great potential to minimize radiation dosage. Clin Res Cardiol. 2016;105(10):858–864. doi: 10.1007/s00392-016-0994-9. PubMed DOI

Steven D, et al. Reduced fluoroscopy during atrial fibrillation ablation: benefits of robotic guided navigation. J Cardiovasc Electrophysiol. 2010;21(1):6–12. doi: 10.1111/j.1540-8167.2009.01592.x. PubMed DOI

Weiss JP, et al. A comparison of remote magnetic irrigated tip ablation versus manual catheter irrigated tip catheter ablation with and without force sensing feedback. J Cardiovasc Electrophysiol. 2016;27(Suppl 1):S5–S10. doi: 10.1111/jce.12901. PubMed DOI

Dragusin O, et al. Evaluation of a radiation protection cabin for invasive electrophysiological procedures. Eur Heart J. 2007;28(2):183–189. doi: 10.1093/eurheartj/ehl420. PubMed DOI

Reddy VY, et al. Catheter ablation of atrial fibrillation without the use of fluoroscopy. Heart Rhythm. 2010;7(11):1644–1653. doi: 10.1016/j.hrthm.2010.07.011. PubMed DOI

Bulava A, Hanis J, Eisenberger M. Catheter ablation of atrial fibrillation using zero-fluoroscopy technique: a randomized trial. Pacing Clin Electrophysiol. 2015;38(7):797–806. doi: 10.1111/pace.12634. PubMed DOI

Cochet H, et al. Atrial structure and function 5 years after successful ablation for persistent atrial fibrillation: an MRI study. J Cardiovasc Electrophysiol. 2014;25(7):671–679. doi: 10.1111/jce.12449. PubMed DOI

Gibson DN, et al. Stiff left atrial syndrome after catheter ablation for atrial fibrillation: clinical characterization, prevalence, and predictors. Heart Rhythm. 2011;8(9):1364–1371. doi: 10.1016/j.hrthm.2011.02.026. PubMed DOI

Shoemaker MB, et al. Left atrial hypertension after repeated catheter ablations for atrial fibrillation. J Am Coll Cardiol. 2011;57(19):1918–1919. doi: 10.1016/j.jacc.2011.01.021. PubMed DOI

Welch TD, et al. Symptomatic pulmonary hypertension with giant left atrial v waves after surgical maze procedures: evaluation by comprehensive hemodynamic catheterization. Heart Rhythm. 2013;10(12):1839–1842. doi: 10.1016/j.hrthm.2013.09.010. PubMed DOI

Witt C, et al. Recurrent dyspnea following multiple ablations for atrial fibrillation explained by the “stiff left atrial syndrome”. Catheter Cardiovasc Interv. 2013;82(5):E747–E749. doi: 10.1002/ccd.24556. PubMed DOI

Pilote L, et al. Stiff left atrial syndrome. Can J Cardiol. 1988;4(6):255–257. PubMed

Khurram IM, et al. Association between left atrial stiffness index and atrial fibrillation recurrence in patients undergoing left atrial ablation. Circ Arrhythm Electrophysiol. 2016;9(3) PubMed

Kosiuk J, et al. Prevalence and predictors of worsened left ventricular diastolic dysfunction after catheter ablation of atrial fibrillation. Int J Cardiol. 2013;168(4):3613–3615. doi: 10.1016/j.ijcard.2013.05.047. PubMed DOI

Ghanbari H, et al. Mortality and cerebrovascular events after radiofrequency catheter ablation of atrial fibrillation. Heart Rhythm. 2014;11(9):1503–1511. doi: 10.1016/j.hrthm.2014.05.003. PubMed DOI

Scherr D, et al. Incidence and predictors of left atrial thrombus prior to catheter ablation of atrial fibrillation. J Cardiovasc Electrophysiol. 2009;20(4):379–384. doi: 10.1111/j.1540-8167.2008.01336.x. PubMed DOI

Liu Y, et al. Incidence and outcomes of cerebrovascular events complicating catheter ablation for atrial fibrillation. Europace. 2016;18(9):1357–1365. doi: 10.1093/europace/euv356. PubMed DOI

Noseworthy PA, et al. Risk of stroke after catheter ablation versus cardioversion for atrial fibrillation: a propensity-matched study of 24,244 patients. Heart Rhythm. 2015;12(6):1154–1161. doi: 10.1016/j.hrthm.2015.02.020. PubMed DOI

Patel D, et al. Long-term functional and neurocognitive recovery in patients who had an acute cerebrovascular event secondary to catheter ablation for atrial fibrillation. J Cardiovasc Electrophysiol. 2010;21(4):412–417. doi: 10.1111/j.1540-8167.2009.01650.x. PubMed DOI

Kochhauser S, et al. Comparison of outcomes after cardioversion or atrial fibrillation ablation in patients with differing periprocedural anticoagulation regimens. Can J Cardiol. 2014;30(12):1541–1546. doi: 10.1016/j.cjca.2014.09.018. PubMed DOI

Kosiuk J, et al. Early cerebral thromboembolic complications after radiofrequency catheter ablation of atrial fibrillation: incidence, characteristics, and risk factors. Heart Rhythm. 2014;11(11):1934–1940. doi: 10.1016/j.hrthm.2014.07.039. PubMed DOI

Abhishek F, et al. Effectiveness of a strategy to reduce major vascular complications from catheter ablation of atrial fibrillation. J Interv Card Electrophysiol. 2011;30(3):211–215. doi: 10.1007/s10840-010-9539-8. PubMed DOI

Aldhoon B, et al. Complications of catheter ablation for atrial fibrillation in a high-volume centre with the use of intracardiac echocardiography. Europace. 2013;15(1):24–32. doi: 10.1093/europace/eus304. PubMed DOI

Mugnai G, et al. Complications in the setting of percutaneous atrial fibrillation ablation using radiofrequency and cryoballoon techniques: a single-center study in a large cohort of patients. Int J Cardiol. 2015;196:42–49. doi: 10.1016/j.ijcard.2015.05.145. PubMed DOI

Murakawa Y, et al. Nationwide survey of catheter ablation for atrial fibrillation: the Japanese catheter ablation registry of atrial fibrillation (J-CARAF)-a report on periprocedural oral anticoagulants. J Arrhythm. 2015;31(1):29–32. doi: 10.1016/j.joa.2014.05.003. PubMed DOI PMC

Palaniswamy C, et al. Catheter ablation of postinfarction ventricular tachycardia: ten-year trends in utilization, in-hospital complications, and in-hospital mortality in the United States. Heart Rhythm. 2014;11(11):2056–2063. doi: 10.1016/j.hrthm.2014.07.012. PubMed DOI

Peichl P, et al. Complications of catheter ablation of ventricular tachycardia: a single-center experience. Circ Arrhythm Electrophysiol. 2014;7(4):684–690. doi: 10.1161/CIRCEP.114.001530. PubMed DOI

Waigand J, et al. Percutaneous treatment of pseudoaneurysms and arteriovenous fistulas after invasive vascular procedures. Catheter Cardiovasc Interv. 1999;47(2):157–164. doi: 10.1002/(SICI)1522-726X(199906)47:2<157::AID-CCD5>3.0.CO;2-Y. PubMed DOI

Lakkireddy D, et al. Feasibility and safety of uninterrupted rivaroxaban for periprocedural anticoagulation in patients undergoing radiofrequency ablation for atrial fibrillation: results from a multicenter prospective registry. J Am Coll Cardiol. 2014;63(10):982–988. doi: 10.1016/j.jacc.2013.11.039. PubMed DOI

Tanaka-Esposito CC, et al. Real-time ultrasound guidance reduces total and major vascular complications in patients undergoing pulmonary vein antral isolation on therapeutic warfarin. J Interv Card Electrophysiol. 2013;37(2):163–168. doi: 10.1007/s10840-013-9796-4. PubMed DOI PMC

Errahmouni A, et al. Ultrasound-guided venous puncture in electrophysiological procedures: a safe method, rapidly learned. Pacing Clin Electrophysiol. 2014;37(8):1023–1028. doi: 10.1111/pace.12386. PubMed DOI

Nejnovějších 20 citací...

Zobrazit více v
Medvik | PubMed

Baseline left atrial low-voltage area predicts recurrence after pulmonary vein isolation: WAVE-MAP AF results

Europace. 2023 Aug 02 ; 25 (9) : .

ISSN 1532-2092 | 1099-5129
Zdroj

Najít záznam

v BMČ

2017 HRS/EHRA/ECAS/APHRS/SOLAECE expert consensus statement on catheter and surgical ablation of atrial fibrillation: executive summary

Najít záznam

Citační ukazatele

Možnosti archivace